Document:

Exhibit 10.6

   

  FORWARD PURCHASE AGREEMENT

   

  This Forward Purchase Agreement (this “Agreement”)
    is entered into as of January 5, 2021, by and between Altimeter Growth Corp. 2, a Cayman Islands exempted company (the Company”),
    and Altimeter Partners Fund, L.P., a Delaware limited partnership (the “Purchaser”).

   

  Recitals

   

  WHEREAS, the Company was incorporated for the purpose of effecting
    a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses
    (a “Business Combination”);

   

  WHEREAS, the Company has confidentially submitted to the U.S.
    Securities and Exchange Commission (the “SEC”) a draft registration statement on Form S-1 (such registration
    statement, as may be amended from time to time, including to reflect changes in terms, the “Registration Statement”)
    for its initial public offering (“IPO”) of Class A ordinary shares of the Company, par value $0.0001 per share
    (the “Class A Share(s)”) at a price of $10.00 per Class A Share.

   

  WHEREAS, following the closing of the IPO (the “IPO
      Closing”), the Company will seek to identify and consummate a Business Combination; and

   

  WHEREAS, the parties hereto wish to enter into this Agreement,
    pursuant to which immediately before the closing of the Company’s initial Business Combination (the “Business Combination
      Closing”), the Company shall issue and sell, and the Purchaser shall purchase, on a private placement basis, up to the
    number of Class A Shares determined pursuant to Section 1(a)(i) hereof (the “Forward Purchase Securities”) on
    the terms and conditions set forth herein.

   

  NOW, THEREFORE, in consideration of the premises, representations,
    warranties and the mutual covenants contained in this Agreement, and for other good and valuable consideration, the receipt, sufficiency
    and adequacy of which are hereby acknowledged, the parties hereto agree as follows:

   

  Agreement

   

  		1.	Sale and Purchase.

   

  		(a)	Forward Purchase Securities.

   

  		(i)	The Company shall issue and sell to the Purchaser, and the Purchaser shall purchase from the Company, up to the number of Forward
          Purchase Securities set forth on the Purchaser’s signature page to this Agreement next to the line item “Maximum
            Number of Forward Purchase Securities,” for an aggregate purchase price of $10.00 multiplied by the number of Forward
          Purchase Securities issued and sold hereunder (the “FPS Purchase Price”). The amounts actually sold pursuant
          to this Section 1(a)(i) shall be determined solely by the Company, subject to Section 1(a)(iv). For the avoidance of doubt, the
          Company is not obligated to issue or sell any Forward Purchase Securities.

   

  
    
      

    

  

   

  		(ii)	The Company shall require the Purchaser to purchase the Forward Purchase Securities pursuant to Section 1(a)(i) hereof by delivering
          notice (the “Company Notice”) to the Purchaser, at least five Business Days before the funding of the FPS Purchase
          Price to an account specified by the Company, specifying the anticipated date of the Business Combination Closing, the number of
          Forward Purchase Securities being sold by the Company to the Purchaser and each Transferee (as defined in Section 4(e)) pursuant
          hereto (which will not exceed the number of Forward Purchase Securities that Purchaser has agreed to purchase pursuant to Section
          1(a)(i) the aggregate purchase price for the Forward Purchase Securities (the “FPS Purchase Price”) to be purchased
          by the Purchaser and instructions for wiring the FPS Purchase Price to an account designated by the Company; provided that,
          if Altimeter Growth Holdings 2 (the “Sponsor”) and/or its affiliates collectively hold 25% or more of the Company’s
          outstanding shares as of the date on which the Company Notice is delivered to the Purchaser, then the Purchaser may, in its sole
          discretion, decline to purchase some or all of the Forward Purchase Securities. At least two Business Days before the anticipated
          date of the Business Combination Closing specified in the Company Notice, the Purchaser shall deliver the FPS Purchase Price in
          cash via wire transfer to the account specified in such notice, to be held in escrow pending the Business Combination Closing.
          If the Business Combination Closing does not occur within thirty (30) days after the Purchaser delivers the FPS Purchase Price
          to such account, the Company shall return to the Purchaser the FPS Purchase Price, provided that the return of the FPS Purchase
          Price placed in escrow shall not terminate this Agreement or otherwise relieve either party of any of its obligations hereunder
          and the Company may provide a subsequent Company Notice pursuant to this Section 1(a)(iii). For the purposes of this Agreement,
          “Business Day” means any day, other than a Saturday or a Sunday, that is neither a legal holiday nor a day on
          which banking institutions are generally authorized or required by law or regulation to close in the City of New York, New York.

   

  		(iii)	The closing of the sale of the Forward Purchase Securities (the “FPS Closing”) shall be held on the same
          date as, and immediately prior to, the Business Combination Closing (such date being referred to as the “Closing Date”).
          At the FPS Closing, the Company will issue to the Purchaser the number of Forward Purchase Securities registered in the name of
          the Purchaser.

   

  		(b)	Delivery of Forward Purchase Securities.

   

  		(i)	The Company shall register the Purchaser as the owner of the number of Forward Purchase Securities with the Company’s
          transfer agent by book 

   

  
    
      

    

  

   

  	 	 	entry on or promptly after (but in no event more than two Business Days after) the FPS Closing Date.

   

  		(ii)	Each book entry for the Forward Purchase Securities shall contain a notation, and each certificate (if any) evidencing the
          Forward Purchase Securities shall be stamped or otherwise imprinted with a legend, in substantially the following form:

   

  “THE SECURITIES REPRESENTED HEREBY HAVE NOT
    BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION,
    AND MAY NOT BE TRANSFERRED IN VIOLATION OF SUCH ACT AND LAWS.”

   

  		(c)	Legend Removal. If the Forward Purchase Securities are eligible to be sold without restriction under, and without the
          Company being in compliance with the current public information requirements of, Rule 144 under the Securities Act of 1933, as
          amended (the “Securities Act”), or there is an effective registration statement covering the resale of the Forward
          Purchase Securities (and the Purchaser provides the Company with a written undertaking to sell its Forward Purchase Securities
          only in accordance with the plan of distribution contained in such registration statement and only if the Purchaser has not been
          informed that the prospectus in such registration statement is not current or the registration statement is no longer effective),
          then at the Purchaser’s request, the Company will cause the Company’s transfer agent to remove the legend set forth
          in Section 1(b)(ii). In connection therewith, if required by the Company’s transfer agent, the Company will promptly cause
          an opinion of counsel to be delivered to and maintained with its transfer agent, together with any other authorizations, certificates
          and directions required by the transfer agent that authorize and direct the transfer agent to transfer such Forward Purchase Securities
          without any such legend; provided that, notwithstanding the foregoing, the Company will not be required to deliver any such opinion,
          authorization, certificate or direction if it reasonably believes that removal of the legend could result in or facilitate transfers
          of Forward Purchase Securities in violation of applicable law.

   

  		(d)	Registration Rights. The Purchaser shall have registration rights as set forth on Exhibit A (the “Registration
            Rights”).

   

  		2.	Representations and Warranties of the Purchaser. The Purchaser represents and warrants to the Company as follows, as
          of the date hereof:

   

  		(a)	Restricted Securities. The Purchaser understands that the offer and sale of the Forward Purchase Securities have not
          been registered under the Securities Act, by reason of a specific exemption from the registration provisions of the Securities
          Act that depends upon, among other things, the bona fide nature of the investment intent and the accuracy of the Purchaser’s
          representations as expressed herein. The Purchaser understands that the Forward Purchase Securities are “restricted 

   

  
    
      

    

  

   

  	 	 	securities”
          under applicable U.S. federal and state securities laws and that, pursuant to these laws, the Purchaser must hold the Forward Purchase
          Securities indefinitely unless they are registered with the SEC and qualified by state authorities, or an exemption from such registration
          and qualification requirements is available. The Purchaser acknowledges that the Company has no obligation to register or qualify
          the Forward Purchase Securities for resale, except pursuant to the Registration Rights. The Purchaser further acknowledges that
          if an exemption from registration or qualification is available, it may be conditioned on various requirements including, but not
          limited to, the time and manner of sale, the holding period for the Forward Purchase Securities, and on requirements relating to
          the Company that are outside of the Purchaser’s control, and which the Company is under no obligation and may not be able
          to satisfy. The Purchaser acknowledges that the Company has confidentially submitted the Registration Statement for its proposed
          IPO to the SEC for review. The Purchaser understands that the offering to the Purchaser of the Forward Purchase Securities is not,
          and is not intended to be, part of the IPO, and that the Purchaser will not be able to rely on the protection of Section 11 of
          the Securities Act with respect to such Forward Purchase Securities.

   

  		(b)	No General Solicitation. Neither the Purchaser, nor any of its officers, directors, employees, agents, shareholders
          or partners, has either directly or indirectly, including, through a broker or finder (i) to its knowledge, engaged in any general
          solicitation, or (ii) published any advertisement in connection with the offer and sale of the Forward Purchase Securities.

   

  		(c)	No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained
          in this Section 2 and in any certificate or agreement delivered pursuant hereto, none of the Purchaser nor any person acting on
          behalf of the Purchaser nor any of the Purchaser’s affiliates (the “Purchaser Parties”) has made, makes
          or shall be deemed to make any other express or implied representation or warranty with respect to the Purchaser and this offering,
          and the Purchaser Parties disclaim any such representation or warranty. Except for the specific representations and warranties
          expressly made by the Company in Section 3 of this Agreement and in any certificate or agreement delivered pursuant hereto, the
          Purchaser Parties specifically disclaim that they are relying upon any other representations or warranties that may have been made
          by the Company.

   

  		3.	Representations and Warranties of the Company. The Company represents and warrants to the Purchaser as follows:

   

  		(a)	Incorporation and Corporate Power. The Company is duly incorporated and validly existing and in good standing as an
          exempted company under the laws of the Cayman Islands and has all requisite corporate power and authority to carry 

   

  
    
      

    

  

   

  	 	 	on its business
          as presently conducted and as proposed to be conducted. The Company has no subsidiaries.

   

  		(b)	Capitalization. As of the date of this Agreement, the authorized share capital of the Company consists of:

   

  		(i)	200,000,000 Class A Shares, none of which are issued and outstanding.

   

  		(ii)	20,000,000 Class B ordinary shares of the Company, par value $0.0001 per share (“Class B Share(s)”), 10,000,000
          of which are issued and outstanding (1,250,000 of which are subject to forfeiture to the extent that the underwriters’ over-allotment
          option in connection with the IPO is not exercised in full). All of the issued and outstanding Class B Shares have been duly authorized,
          are fully paid and nonassessable and were issued in compliance with all applicable federal and state securities laws.

   

  		(iii)	1,000,000 preference shares, none of which are issued and outstanding.

   

  		(c)	Authorization. All corporate action required to be taken by the Company’s Board of Directors and shareholders
          in order to authorize the Company to enter into this Agreement, and to issue the Forward Purchase Securities at the FPS Closing,
          and the securities issuable upon conversion or exercise of the Forward Purchase Securities, has been taken or will be taken before
          the FPS Closing. All action on the part of the shareholders, directors and officers of the Company necessary for the execution
          and delivery of this Agreement, the performance of all obligations of the Company under this Agreement to be performed as of the
          FPS Closing and the issuance and delivery of the Forward Purchase Securities and the securities issuable upon conversion or exercise
          of the Forward Purchase Securities has been taken or will be taken before the FPS Closing. This Agreement, when executed and delivered
          by the Company, shall constitute the valid and legally binding obligation of the Company, enforceable against the Company in accordance
          with its terms except (i) as limited by applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance, or
          other laws of general application relating to or affecting the enforcement of creditors’ rights generally, (ii) as limited
          by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies, or (iii) to the extent
          the indemnification provisions contained in the Registration Rights may be limited by applicable federal or state securities laws.

   

  		(d)	Valid Issuance of Forward Purchase Securities. The Forward Purchase Securities, when issued, sold and delivered in accordance
          with the terms and for the consideration set forth in this Agreement and the Company’s memorandum and articles of association
          (the “Charter”), and the securities issuable upon conversion or exercise of the Forward Purchase Securities,
          when issued in accordance with the terms of this Agreement, and registered in the register of members of the Company, will be validly
          issued, fully paid and nonassessable and free of all preemptive or similar rights, taxes, liens, encumbrances and charges with
          respect 

   

  
    
      

    

  

   

  	 	 	to the issue thereof and restrictions on transfer other than restrictions on transfer specified under this Agreement, applicable
          state and federal securities laws and liens or encumbrances created by or imposed by the Purchaser. Assuming the accuracy of the
          representations of the Purchaser in this Agreement and subject to the filings described in Section 3(e) below, the Forward Purchase
          Securities will be issued in compliance with all applicable federal and state securities laws.

   

  		(e)	Governmental Consents and Filings. Assuming the accuracy of the representations and warranties made by the Purchaser
          in this Agreement, no consent, approval, order or authorization of, or registration, qualification, designation, declaration or
          filing with, any federal, state or local governmental authority is required on the part of the Company in connection with the consummation
          of the transactions contemplated by this Agreement, except for applicable requirements of the Securities Act and applicable state
          securities laws.

   

  		(f)	Compliance with Other Instruments. The execution, delivery and performance of this Agreement and the consummation of
          the transactions contemplated by this Agreement will not result in any violation or default (i) of any provisions of its Charter
          or other governing documents, (ii) of any instrument, judgment, order, writ or decree to which it is a party or by which it is
          bound, (iii) under any note, indenture or mortgage to which it is a party or by which it is bound, (iv) under any lease, agreement,
          contract or purchase order to which it is a party or by which it is bound or (v) of any provision of federal or state statute,
          rule or regulation applicable to the Company, in each case (other than clause (i)) which would have a material adverse effect on
          the Company or its ability to consummate the transactions contemplated by this Agreement.

   

  		(g)	Operations. As of the date hereof, the Company has not conducted, and before the IPO Closing the Company will not conduct,
          any operations other than organizational activities and activities in connection with offerings of its securities.

   

  		(h)	Foreign Corrupt Practices. Neither the Company, nor any director, officer, agent, employee or other Person acting on
          behalf of the Company has, in the course of its actions for, or on behalf of, the Company (i) used any corporate funds for any
          unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect
          unlawful payment to any foreign or domestic government official or employee from corporate funds; (iii) violated or is in violation
          of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended; or (iv) made any unlawful bribe, rebate, payoff,
          influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee.

   

  		(i)	Compliance with Anti-Money Laundering Laws. The operations
          of the Company are and have been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements
          and all other applicable U.S. and non-U.S. anti-money laundering laws and regulations, including, but not limited to,

   

  
    
      

    

  

   

  	 	 	those of the Currency and Foreign Transactions Reporting Act of
          1970, as amended, the USA Patriot Act of 2001 and the applicable money laundering statutes of all applicable jurisdictions, the
          rules and regulations thereunder and any related or similar rules, regulations or guidelines, issued, administered or enforced
          by any governmental agency (collectively, the “Anti-Money Laundering Laws”), and no action, suit or proceeding
          by or before any court or governmental agency, authority or body or any arbitrator involving the Company with respect to the Anti-Money
          Laundering Laws is pending or, to the knowledge of the Company, threatened.

   

  		(j)	Absence of Litigation. There is no action, suit, proceeding, inquiry or investigation before or by any court, public
          board, government agency, self-regulatory organization or body pending or, to the knowledge of the Company, threatened against
          or affecting the Company or any of the Company’s officers or directors, whether of a civil or criminal nature or otherwise,
          in their capacities as such.

   

  		(k)	No General Solicitation. Neither the Company, nor any of its officers, directors, employees, agents or shareholders
          has either directly or indirectly, including, through a broker or finder (i) engaged in any general solicitation, or (ii) published
          any advertisement in connection with the offer and sale of the Forward Purchase Securities.

   

  		(l)	No Other Representations and Warranties; Non-Reliance. Except for the specific representations and warranties contained
          in this Section 3 and in any certificate or agreement delivered pursuant hereto, the Company has not made and does not make nor
          shall be deemed to make any other express or implied representation or warranty with respect to the Company, this offering, the
          proposed IPO or a potential Business Combination, and the Company disclaims any such representation or warranty. Except for the
          specific representations and warranties expressly made by the Purchaser in Section 2 of this Agreement and in any certificate or
          agreement delivered pursuant hereto, the Company specifically disclaims that it is relying upon any other representations or warranties
          that may have been made by the Purchaser Parties.

   

  		4.	Additional Agreements and Acknowledgements and Waivers of the Purchaser.

   

  		(a)	Trust Account.

   

  		(i)	The Purchaser hereby acknowledges that it is aware that the Company will establish a trust account (the “Trust Account”)
          for the benefit of its public shareholders upon the closing of the IPO. The Purchaser, for itself and its affiliates, hereby agrees
          that it has no right, title, interest or claim of any kind in or to any monies held in the Trust Account, or any other asset of
          the Company as a result of any liquidation of the Company, except for redemption and liquidation rights, if any, the Purchaser
          may have in respect of any Class A Shares held by it.

   

  
    
      

    

  

   

  		(ii)	The Purchaser hereby agrees that it shall have no right of set-off or any right, title, interest or claim of any kind (“Claim”)
          to, or to any monies in, the Trust Account, and hereby irrevocably waives any Claim to, or to any monies in, the Trust Account
          that it may have now or in the future, except for redemption and liquidation rights, if any, the Purchaser may have in respect
          of any Class A Shares held by it. In the event the Purchaser has any Claim against the Company under this Agreement, the Purchaser
          shall pursue such Claim solely against the Company and its assets outside the Trust Account and not against the property or any
          monies in the Trust Account, except for redemption and liquidation rights, if any, the Purchaser may have in respect of any Class
          A Shares held by it.

   

  		(b)	Redemption and Liquidation. The Purchaser hereby waives, with respect to any Forward Purchase
          Securities held by it, any redemption rights it may have in connection with (i) the consummation of a Business Combination, including
          any such rights available in the context of a shareholder vote to approve such Business Combination and (ii) any shareholder vote
          to approve an amendment to the Charter (A) to modify the substance or timing of the Company’s obligation to redeem 100% of
          the Company’s Class A Shares if the Company does not complete its Business Combination within 24 months (or 27 months, as
          applicable) after the closing of the IPO or (B) with respect to any other provisions relating to the rights of the Company’s
          Class A Shares, it being understood that the Purchaser shall be entitled to redemption and liquidation rights with respect to any
          Class A Shares held by it.

   

  		(c)	Voting. The Purchaser hereby agrees that if the Company seeks shareholder approval of a proposed Business Combination,
          then in connection with such proposed Business Combination, the Purchaser shall vote any Class A Shares owned by it in favor of
          any proposed Business Combination. If the Purchaser fails to vote any Class A Shares it is required to vote hereunder in favor
          of a Proposed Business Combination, the Purchaser hereby grants to the Company and any representative designated by the Company
          without further action by the Purchaser a limited irrevocable power of attorney to effect such vote on behalf of the Purchaser,
          which power of attorney shall be deemed to be coupled with an interest.

   

  		(d)	[Reserved].

   

  		(e)	Transfer. This Agreement and all of the Purchaser’s rights and obligations hereunder (including the Purchaser’s
          obligation to purchase the Forward Purchase Securities) may be transferred or assigned, at any time and from time to time, in whole
          or in part, to one or more affiliates of Purchaser, but not to other third parties (each such transferee, a “Transferee”).
          Upon any such assignment:

   

  		(i)	the applicable Transferee shall execute a signature page
          to this Agreement, substantially in the form of the Purchaser’s signature page hereto (the “Joinder Agreement”),
          which shall reflect the maximum number of Forward Purchase Securities to be purchased by such Transferee (the

   

  
    
      

    

  

   

  	 	 	“Transferee Securities”), and, upon such execution, such Transferee
          shall have all the same rights and obligations of the Purchaser hereunder with respect to the Transferee Securities, and references
          herein to the “Purchaser” shall be deemed to refer to and include any such Transferee with respect to such Transferee
          and to its Transferee Securities; provided, that any representations, warranties, covenants and agreements of the Purchaser and
          any such Transferee shall be several and not joint and shall be made as to the Purchaser or any such Transferee, as applicable,
          as to itself only; and

   

  		(ii)	upon a Transferee’s execution and delivery of a Joinder Agreement, the maximum number of Forward Purchase Securities
          to be purchased by the Purchaser hereunder shall be reduced by the maximum number of Forward Purchase Securities to be purchased
          by the applicable Transferee pursuant to the applicable Joinder Agreement, which reduction shall be evidenced by the Purchaser
          and the Company amending Schedule A to this Agreement to reflect each transfer and updating the “Maximum Number of Forward
          Purchase Securities” and “Aggregate Purchase Price for Forward Purchase Securities” on the Purchaser’s
          signature page hereto to reflect such reduced number of Forward Purchase Securities, and each of the Transferee’s and the
          Purchaser’s purchase obligations shall be subject to allocation pursuant to Section 1(a)(iv) herein. For the avoidance of
          doubt, this Agreement need not be amended and restated in its entirety, but only Schedule A and the Purchaser’s signature
          page hereto need be so amended and updated and executed by each of the Purchaser and the Company upon the occurrence of any such
          transfer of Transferee Securities.

   

  		(f)	No Short Sales. The Purchaser hereby agrees that neither it, nor any person or entity acting on its behalf or pursuant
          to any understanding with it, will engage in any Short Sales with respect to securities of the Company prior to the Business Combination
          Closing. For purposes of this Section 4(b), “Short Sales” shall include, without limitation, all “short sales”
          as defined in Rule 200 promulgated under Regulation SHO under the Securities Exchange Act of 1934, as amended (the “Exchange
            Act”), and all types of direct and indirect stock pledges (other than pledges in the ordinary course of business as part
          of prime brokerage arrangements), forward sale contracts, options, puts, calls, swaps and similar arrangements (including on a
          total return basis), and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers.

   

  		5.	Additional Agreement of the Company.

   

  		(a)	Exchange Listing. The Company will use commercially reasonable efforts to effect the listing of the Class A Shares on
          the a national securities exchange.

   

  		(b)	QEF Election Information. Until the Business Combination,
          the Sponsor shall use commercially reasonable efforts to determine whether, in any year, the

   

  
    
      

    

  

   

  	 	 	Company or any subsidiary of the Company is deemed to be a “passive foreign investment company”
          (a “PFIC”) within the meaning of U.S. Internal Revenue Code of 1986, as amended, and the regulations promulgated
          thereunder (collectively, the “Code”). Until the Business Combination, if the Sponsor determines that the Company
          or any subsidiary of the Company is a PFIC in any year, for the year of determination and for each year thereafter during which
          the Purchaser holds an equity interest in the Company, the Company or its subsidiary shall use commercially reasonable efforts
          to (i) make available to the Purchaser the information that may be required to make or maintain a “qualified electing fund”
          election under the Code with respect to the Company and (ii) furnish the information required to be reported under Section 1298(f)
          of the Code and/or, upon request, necessary in order to make the election described in Section 1291(d)(2)(B) of the Code.

   

  		6.	FPS Closing Conditions.

   

  		(a)	The obligation of the Purchaser to purchase the Forward Purchase Securities at the FPS Closing under this Agreement shall be
          subject to the fulfillment, at or before the FPS Closing of each of the following conditions, any of which, to the extent permitted
          by applicable laws, may be waived by the Purchaser:

   

  		(i)	the Business Combination shall be consummated substantially concurrently with, and immediately following, the purchase of Forward
          Purchase Securities;

   

  		(ii)	The Company shall have delivered to the Purchaser a certificate evidencing the Company’s good standing as a Cayman Islands
          exempted limited company, as of a date within 10 Business Days of the FPS Closing;

   

  		(iii)	the representations and warranties of the Company set forth in Section 3 of this Agreement shall have been true and correct
          as of the date hereof and shall be true and correct, in the case of the Company, as of the FPS Closing, as applicable, with the
          same effect as though such representations and warranties had been made on and as of such date (other than any such representation
          or warranty that is made by its terms as of a specified date, which shall be true and correct as of such specified date), except,
          in the case of the Company, where the failure to be so true and correct would not have a material adverse effect on the Company
          or its ability to consummate the transactions contemplated by this Agreement;

   

  		(iv)	the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
          required by this Agreement to be performed, satisfied or complied with by the Company at or before the FPS Closing; and

   

  
    
      

    

  

   

  		(v)	no order, writ, judgment, injunction, decree, determination, or award shall have been entered by or with any governmental,
          regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint or
          prohibition shall be in effect, preventing the purchase by the Purchaser of the Forward Purchase Securities.

   

  		(b)	The obligation of the Company to sell the Forward Purchase Securities at the FPS Closing under this Agreement shall be subject
          to the fulfillment, at or before the FPS Closing of each of the following conditions, any of which, to the extent permitted by
          applicable laws, may be waived by the Company:

   

  		(i)	the Business Combination shall be consummated substantially concurrently with, and immediately following, the purchase of Forward
          Purchase Securities;

   

  		(ii)	the representations and warranties of the Purchaser set forth in Section 2 of this Agreement shall have been true and correct
          as of the date hereof and shall be true and correct as of the FPS Closing, as applicable, with the same effect as though such representations
          and warranties had been made on and as of such date (other than any such representation or warranty that is made by its terms as
          of a specified date, which shall be true and correct as of such specified date), except where the failure to be so true and correct
          would not have a material adverse effect on the Purchaser or its ability to consummate the transactions contemplated by this Agreement;

   

  		(iii)	the Purchaser shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
          required by this Agreement to be performed, satisfied or complied with by the Purchaser at or before the FPS Closing; and

   

  		(iv)	no order, writ, judgment, injunction, decree, determination, or award shall have been entered by or with any governmental,
          regulatory, or administrative authority or any court, tribunal, or judicial, or arbitral body, and no other legal restraint or
          prohibition shall be in effect, preventing the purchase by the Purchaser of the Forward Purchase Securities.

   

  		7.	Termination. This Agreement may be terminated at any time before the FPS Closing:

   

  		(a)	by mutual written consent of the Company and the Purchaser;

   

  		(b)	automatically

   

  		(i)	if the IPO is not consummated on or before June 30, 2021;

   

  		(ii)	if the Business Combination is not consummated within 24 months from the closing of the IPO (or 27 months from the closing
          of the IPO if the Company has executed a letter of intent, agreement in principle or definitive agreement for the Business Combination
          within 24 months from 

   

  
    
      

    

  

   

  	 	 	the IPO’s closing of the IPO but has not completed the Business Combination within such 24-month period),
          unless extended upon approval of the Company’s shareholders in accordance with the Charter; or

   

  		(iii)	if the Company becomes subject to any voluntary or involuntary petition under the United States federal bankruptcy laws or
          any state insolvency law, in each case which is not withdrawn within 60 days after being filed, or a receiver, fiscal agent or
          similar officer is appointed by a court for business or property of the Company, in each case which is not removed, withdrawn or
          terminated within 60 days after such appointment;

   

  In the event of any termination of this Agreement pursuant
    to this Section 7, the FPS Purchase Price (and interest thereon, if any), if previously paid, and the Purchaser’s funds paid
    in connection herewith shall be promptly returned to the Purchaser, and thereafter this Agreement shall forthwith become null and
    void and have no effect, without any liability on the part of the Purchaser or the Company and their respective directors, officers,
    employees, partners, managers, members, or shareholders and all rights and obligations of each party shall cease; provided,
    however, that nothing contained in this Section 7 shall relieve any party from liabilities or damages arising out of any
    fraud or willful breach by such party of any of its representations, warranties, covenants or agreements contained in this Agreement.

   

  		8.	General Provisions.

   

  		(a)	Notices. All notices and other communications given or made pursuant to this Agreement shall be in writing and shall
          be deemed effectively given upon the earlier of actual receipt, and (a) personal delivery to the party to be notified, (b) when
          sent, if sent by electronic mail or facsimile (if any) during normal business hours of the recipient, and if not sent during normal
          business hours, then on the recipient’s next Business Day, (c) five Business Days after having been sent by registered or
          certified mail, return receipt requested, postage prepaid, or (d) one Business Day after deposit with a nationally recognized overnight
          courier, freight prepaid, specifying next Business Day delivery, with written verification of receipt. All communications sent
          to the Company shall be sent to: Altimeter Growth Corp. 2, c/o Altimeter Capital Management, LP, 2550 Sand Hill Road, Suite 150,
          Menlo Park, CA 94025, Attn: Hab Siam, hab@altimeter.com, with a copy to the Company’s counsel at: Ropes & Gray LLP, 1211
          Avenue of the Americas, New York, NY 10036-8704, Attn: Paul Tropp, Esq., email: paul.tropp@ropesgray.com.

   

  All communications to the Purchaser shall be sent to
    the Purchaser’s address as set forth on the signature page hereof, or to such e-mail address, facsimile number (if any) or
    address as subsequently modified by written notice given in accordance with this Section 8(a).

   

  
    
      

    

  

   

  		(b)	No Finder’s Fees. Each of the parties represents that it neither is nor will be obligated for any finder’s
          fee or commission in connection with this transaction. The Purchaser agrees to indemnify and to hold harmless the Company from
          any liability for any commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction
          (and the costs and expenses of defending against such liability or asserted liability) for which the Purchaser or its respective
          officers, employees or representatives is responsible. The Company agrees to indemnify and hold harmless the Purchaser from any
          liability for any commission or compensation in the nature of a finder’s or broker’s fee arising out of this transaction
          (and the costs and expenses of defending against such liability or asserted liability) for which the Company or any of its officers,
          employees or representatives is responsible.

   

  		(c)	Survival of Representations and Warranties. All of the representations and warranties contained herein shall survive
          the FPS Closing.

   

  		(d)	Entire Agreement. This Agreement, together with any documents, instruments and writings that are delivered pursuant
          hereto or referenced herein, constitutes the entire agreement and understanding of the parties hereto in respect of its subject
          matter and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral,
          to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby.

   

  		(e)	Successors. All of the terms, agreements, covenants, representations, warranties, and conditions of this Agreement are
          binding upon, and inure to the benefit of and are enforceable by, the parties hereto and their respective successors. Nothing in
          this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors
          and assigns any rights, remedies, obligations or liabilities under or by reason of this Agreement, except as expressly provided
          in this Agreement.

   

  		(f)	Assignments. Except as otherwise specifically provided herein, no party hereto may assign either this Agreement or any
          of its rights, interests, or obligations hereunder without the prior written approval of the other parties. Notwithstanding the
          foregoing, the Purchaser may assign and delegate all or a portion of its rights and obligations to purchase the Forward Purchase
          Securities to one or more other persons upon the consent of the Company (which consent shall not be unreasonably conditioned, withheld
          or delayed); provided, however, that no consent of the Company shall be required if such assignment or delegation is to an affiliate
          of Purchaser; provided, further, that no such assignment or delegation shall relieve the Purchaser of its obligations hereunder
          (including its obligation to purchase the number of Forward Purchase Shares) and the Company shall be entitled to pursue all rights
          and remedies against the Purchaser subject to the terms and conditions hereof.

   

  
    
      

    

  

   

  		(g)	Counterparts. This Agreement may be executed in two or more counterparts, each of which will be deemed an original but
          all of which together will constitute one and the same instrument.

   

  		(h)	Headings. The section headings contained in this Agreement are inserted for convenience only and will not affect in
          any way the meaning or interpretation of this Agreement.

   

  		(i)	Governing Law. This Agreement, the entire relationship of the parties hereto, and any dispute between the parties (whether
          grounded in contract, tort, statute, law or equity) shall be governed by, construed in accordance with, and interpreted pursuant
          to the laws of the State of New York, without giving effect to its choice of laws principles.

   

  		(j)	Jurisdiction. The parties hereto (i) hereby irrevocably and unconditionally submit to the jurisdiction of the state
          courts of New York and to the jurisdiction of the United States District Court for the Southern District of New York for the purpose
          of any suit, action or other proceeding arising out of or based upon this Agreement, (b) agree not to commence any suit, action
          or other proceeding arising out of or based upon this Agreement except in state courts of New York or the United States District
          Court for the Southern District of New York, and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or
          otherwise, in any such suit, action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named
          courts, that its property is exempt or immune from attachment or execution, that the suit, action or proceeding is brought in an
          inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof
          may not be enforced in or by such court.

   

  		(k)	WAIVER OF JURY TRIAL. THE PARTIES HERETO HEREBY WAIVE ANY RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY LITIGATION
            PURSUANT TO THIS AGREEMENT AND THE TRANSACTIONS CONTEMPLATED HEREBY.

   

  		(l)	Amendments. This Agreement may not be amended, modified or waived as to any particular provision, except with the written
          consent of the Company and the Purchaser.

   

  		(m)	Severability. The provisions of this Agreement will be deemed severable and the invalidity or unenforceability of any
          provision will not affect the validity or enforceability of the other provisions hereof; provided that if any provision of this
          Agreement, as applied to any party hereto or to any circumstance, is adjudged by a governmental authority, arbitrator, or mediator
          not to be enforceable in accordance with its terms, the parties hereto agree that the governmental authority, arbitrator, or mediator
          making such determination will have the power to modify the provision in a manner consistent with its objectives such that it is 

   

  
    
      

    

  

   

  	 	 	enforceable, and/or to delete specific words or phrases, and in its reduced form, such provision will then be enforceable and will
          be enforced.

   

  		(n)	Expenses. Each of the Company and the Purchaser will bear its own costs and expenses incurred in connection with the
          preparation, execution and performance of this Agreement and the consummation of the transactions contemplated hereby, including
          all fees and expenses of agents, representatives, financial advisors, legal counsel and accountants. The Company shall be responsible
          for the fees of its transfer agent; stamp taxes and all The Depository Trust Company fees associated with the issuance of the Securities
          and the securities issuable upon conversion or exercise of the Forward Purchase Securities.

   

  		(o)	Construction. The parties hereto have participated jointly in the negotiation and drafting of this Agreement. If an
          ambiguity or question of intent or interpretation arises, this Agreement will be construed as if drafted jointly by the parties
          hereto and no presumption or burden of proof will arise favoring or disfavoring any party hereto because of the authorship of any
          provision of this Agreement. Any reference to any federal, state, local, or foreign law will be deemed also to refer to law as
          amended and all rules and regulations promulgated thereunder, unless the context requires otherwise. The words “include,”
          “includes,” and “including” will be deemed to be followed by “without limitation.” Pronouns
          in masculine, feminine, and neuter genders will be construed to include any other gender, and words in the singular form will be
          construed to include the plural and vice versa, unless the context otherwise requires. The words “this Agreement,”
          “herein,” “hereof,” “hereby,” “hereunder,” and words of similar import refer to
          this Agreement as a whole and not to any particular subdivision unless expressly so limited. The parties hereto intend that each
          representation, warranty, and covenant contained herein will have independent significance. If any party hereto has breached any
          representation, warranty, or covenant contained herein in any respect, the fact that there exists another representation, warranty
          or covenant relating to the same subject matter (regardless of the relative levels of specificity) which such party hereto has
          not breached will not detract from or mitigate the fact that such party hereto is in breach of the first representation, warranty,
          or covenant.

   

  		(p)	Waiver. No waiver by any party hereto of any default, misrepresentation, or breach of warranty or covenant hereunder,
          whether intentional or not, may be deemed to extend to any prior or subsequent default, misrepresentation, or breach of warranty
          or covenant hereunder or affect in any way any rights arising because of any prior or subsequent occurrence.

   

  		(q)	Confidentiality. Except as may be required by law, regulation or applicable stock exchange listing requirements, unless
          and until the transactions contemplated hereby and the terms hereof are publicly announced or otherwise publicly disclosed by the
          Company, the parties hereto shall keep confidential and shall not publicly disclose the existence or terms of this Agreement.

   

  
    
      

    

  

   

  [Signature page follows]

   

  
    
      

    

  

   

  IN WITNESS WHEREOF, the undersigned have executed this Agreement
    to be effective as of the date first set forth above.

   

  

  

  	PURCHASER:	Notice/Contact Information:
	 	 
	
          ALTIMETER PARTNERS FUND, L.P.

           

           

          

        	
          Altimeter Partners Fund, L.P.

          

          c/o Altimeter Capital Management, LP, 

            Attn: John Kiernan

          

          One International Place, Suite 4610, 

            Boston, MA 02110 

        

   

  

  	By:	/s/ John Kiernan	 
	Name: 	John Kiernan III
	Title:	Member of the General Partner

   

   

  

   

  

  	COMPANY:	 
	 	 
	ALTIMETER GROWTH CORP. 2	
          Hab Siam

          

          Altimeter Capital Management, LP, 

            2550 Sand Hill Road, Suite 150

          

          Menlo Park, CA 94025 

        

   

  

  	/s/ Hab Siam	 
	Hab Siam
	General Counsel

   

   

  

  	Forward Purchase Securities:	5,000,000
	Aggregate Purchase Price for Forward Purchase Securities:	$50,000,000

   

  [Signature Page to
      Altimeter Forward Purchase Agreement]

   

  
    
      

    

  

   

  Exhibit A

   

  Registration Rights

   

  		1.	The Company shall use its reasonable best efforts to (i) within 30 days after the Business Combination Closing, file a registration
          statement for a secondary offering (including any successor registration statement covering the resale of the Registrable Securities,
          a “Resale Shelf”) of (x) the Forward Purchase Securities, (y) any other Class A Shares that may be acquired
          by the Purchaser after the date of this Agreement, including any time after the Business Combination Closing and (z) any other
          equity security of the Company issued or issuable with respect to the securities referred to in clauses (x) and (y) by way of a
          share capitalization or share split or in connection with a combination of shares, recapitalization, merger, consolidation or reorganization
          (collectively, the “Registrable Securities”) for an offering to be made on a continuous basis pursuant to Rule
          415 of the Securities Act registering the resale of the Registrable Securities from time to time; provided, that if Form
          S-3 is unavailable for such a registration, the Company shall register the resale of the Registrable Securities on another appropriate
          form and undertake to register the Registrable Securities on Form S-3 as soon as such form is available, (ii) cause the Resale
          Shelf to be declared effective under the Securities Act promptly thereafter, but in no event later than ninety (90) days after
          the closing of the Business Combination and (iii) maintain the effectiveness of such Resale Shelf with respect to the Purchaser’s
          Registrable Securities and to ensure the Resale Shelf does not contain a material omission or misstatement, including by way of
          amendment or other update, as required, until the earlier of (A) the date on which the Purchaser ceases to hold Registrable Securities
          covered by such Resale Shelf and (B) the date all of the Purchaser’s Registrable Securities covered by the Resale Shelf can
          be sold publicly without restriction or limitation under Rule 144 under the Securities Act and without the requirement to be in
          compliance with Rule 144(c)(1) under the Securities Act; and provided, further, with respect to Registrable Securities
          acquired after the Business Combination Closing, the Company shall only be obligated to amend the Resale Shelf or file a new registration
          statement that will constitute a Resale Shelf to include such Registrable Securities on two occasions, each upon the written request
          of the Purchaser with respect to at least 1,000,000 Registrable Securities.

   

  		2.	In the event the Company is prohibited by applicable rule,
          regulation or interpretation by the staff (“Staff”) of the Securities and Exchange Commission (“SEC”)
          from registering all of the Registrable Securities on the Resale Shelf or the Staff requires that the Purchaser be specifically
          identified as an “underwriter” in order to permit such registration statement to become effective, and the Purchaser
          does not consent in writing to being so named as an underwriter in such registration statement, the Company agrees to promptly
          (i) inform each of the holders thereof and use its reasonable best efforts to file amendments to the Resale Shelf as required
          by the SEC and/or (ii) withdraw the Resale Shelf and file a new registration statement (a “New Registration Statement”),
          on Form S-3, or if Form S-3 is not then available to the Company for such registration statement, on such other form available
          to register for resale the Registrable Securities as a secondary offering; the number of Registrable Securities to be registered
          on the Resale Shelf will be reduced on a pro rata basis among all the holders of Registrable Securities

   

  
    
      

    

  

   

  	 	 	 to be so included, unless otherwise required by the Staff, so that the number of Registrable
          Securities to be registered is permitted by Staff and the Purchaser is not required to be named as an “underwriter”;
          provided, that any Registrable Securities not registered due to this paragraph 2 shall thereafter as soon as allowed by
          the SEC guidance be registered to the extent the prohibition no longer is applicable.

   

  		3.	If at any time the Company proposes to file a registration statement (a “Registration Statement”) on its
          own behalf, or on behalf of any other Persons who have registration rights (“Other Holders”), relating to an
          underwritten offering of ordinary shares, or engage in an Underwritten Shelf Takedown (as defined below) off an existing registration
          statement (a “Company Offering”), then the Company will provide the Purchaser with notice in writing (an “Offer
            Notice”) at least five Business Days before such filing, which Offer Notice will offer to include in the Registration
          Statement, the Purchaser’s Registrable Securities. Within five Business Days (or, in the case of an Offer Notice delivered
          to the Purchaser in connection with an Underwritten Shelf Takedown, within three Business Days) after receiving the Offer Notice,
          the Purchaser may make a written request to the Company to include some or all of the Purchaser’s Registrable Securities
          in the Registration Statement. If the underwriter(s) for any Company Offering advise the Company that marketing factors require
          a limitation on the number of securities that may be included in the Company Offering, the number of securities to be so included
          shall be allocated as follows: (i) first, to the Company and the Other Holders, if any; and (ii) second, to the requesting Purchaser.

   

  		4.	At any time during which the Company has an effective Resale Shelf with respect to any Purchaser’s Registrable Securities,
          any such Purchaser may make a written request (which request shall specify the intended method of disposition thereof) (a “Shelf
            Takedown Request”) to the Company to effect a sale, of all or a portion of the Purchaser’s Registrable Securities
          that are covered by the Resale Shelf, and the Company shall use commercially reasonable efforts to file, to the extent required
          by applicable law or regulation, a prospectus supplement (a “Shelf Takedown Prospectus Supplement”) for such
          purpose as soon as reasonably practicable following receipt of a Shelf Takedown Request. Such Purchaser may request that any such
          sale be conducted as an underwritten public offering (an “Underwritten Shelf Takedown”).

   

  		5.	The determination of whether any offering of Registrable Securities pursuant to the Resale Shelf or a Shelf Takedown Prospectus
          Supplement will be an Underwritten Shelf Takedown shall be made in the sole discretion of the Purchaser(s), after consultation
          with the Company, and the Purchaser(s) shall have the right, after consultation with the Company, to determine the plan of distribution,
          including the price at which the Registrable Securities are to be sold and the underwriting commissions, discounts and fees. The
          Purchaser(s) shall select the investment banker or bankers and managers to administer the offering, including the lead managing
          underwriter (provided that such investment banker or bankers and managers shall be reasonably satisfactory to the Company).

   

  		6.	In connection with any Underwritten Shelf Takedown, the Company shall enter into such customary agreements and take all such
          other actions in connection therewith (including 

   

  
    
      

    

  

   

  	 	 	those requested by the Purchasers) in order to facilitate the disposition of such
          Registrable Securities as are reasonably necessary or required, and in such connection enter into a customary underwriting agreement
          that provides for customary opinions, comfort letters and officer’s certificates and other customary deliverables.

   

  		7.	The Company shall pay all fees and expenses incident to the performance of or compliance with its obligation to prepare, file
          and maintain the Resale Shelf (including the fees of its counsel and accountants). The Company shall also pay all Registration
          Expenses. For purposes of this paragraph 7, “Registration Expenses” shall mean the out-of-pocket expenses of
          a Company Offering or an Underwritten Shelf Takedown, including, without limitation, the following: (i) all registration, qualification
          and filing fees (including fees with respect to filings required to be made with FINRA) and any securities exchange on which the
          Registrable Securities are then listed; (ii) fees and expenses of compliance with securities or blue sky laws (including reasonable
          fees and disbursements of one counsel to the underwriters in connection with blue sky qualifications of the Registrable Securities);
          (iii) printing, messenger, telephone and delivery expenses; (iv) reasonable fees and disbursements of counsel for the Company;
          (v) reasonable fees and disbursements of all independent registered public accountants of the Company incurred specifically in
          connection with such Underwritten Shelf Takedown; (vi) reasonable fees and expenses of one legal counsel selected by the Purchaser
          and (vii) and, for the avoidance of doubt, the Company also shall pay all of its internal expenses (including, without limitation,
          all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit
          or quarterly review, the expense of any liability insurance and the expenses and fees for listing the securities to be registered
          on each securities exchange on which similar securities issued by the Company are then listed; provided, that it is understood
          and agreed that the Company shall not be responsible for any underwriting fees, discounts, selling commissions, underwriter expenses
          and share transfer taxes relating to the registration and sale of the Purchaser’s Registrable Securities.

   

  		8.	The Company may suspend the use of a prospectus included in the Resale Shelf by furnishing to the Purchaser a written notice
          (“Suspension Notice”) stating that in the good faith judgment of the Company, it would be either (i) prohibited
          by the Company’s insider trading policy (as if the Purchaser were covered by such policy) or (ii) materially detrimental
          to the Company and its shareholders for such prospectus to be used at such time. The Company’s right to suspend the use of
          such prospectus under clause (ii) of the preceding sentence may be exercised for a period of not more than 60 days after the date
          of such notice to the Purchaser; provided such period may be extended for an additional 30 days with the consent of a majority-in-interest
          of the holders of Registrable Securities covered by the Resale Shelf; provided further, that such right to suspend the use of a
          prospectus shall be exercised by the Company not more than once in any 12 month period. A holder of Registrable Securities shall
          not effect any sales of Registrable Securities pursuant to the Resale Shelf at any time after it has received a Suspension Notice
          from the Company and before receipt of an End of Suspension Notice (as defined below). The holders may recommence effecting sales
          of the Registrable Securities pursuant to the Resale Shelf following further written notice to such effect (an “End of
            Suspension Notice”) from the Company to the holders. The Company shall act in good

   

  
    
      

    

  

   

  	 	 	 faith to permit any suspension period
          contemplated by this paragraph to be concluded as promptly as reasonably practicable.

   

  		9.	The Purchaser agree that, except as required by applicable law, the Purchaser shall treat as confidential the receipt of any
          Suspension Notice (provided that in no event shall such notice contain any material non-public information of the Company) hereunder
          and shall not disclose or use the information contained in such Suspension Notice without the prior written consent of the Company
          until such time as the information contained therein is or becomes public, other than as a result of disclosure by a holder of
          Registrable Securities in breach of the terms of this Agreement.

   

  		10.	The Company shall indemnify and hold harmless the Purchaser, their directors and officers, partners, members, managers, affiliates,
          employees, agents, and representatives of the Purchaser and each person, if any, who controls any Purchaser within the meaning
          of the Securities Act and the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and the officers,
          directors, partners, members, managers, agents, affiliates, employees and investment advisers of each such controlling person (collectively,
          “Indemnified Persons”), to the fullest extent permitted by applicable law, from and against any losses, claims,
          damages, liabilities, joint or several, costs (including reasonable costs of preparation and reasonable attorneys’ fees)
          and expenses, judgments, fines, penalties, interest, settlements or other amounts arising from any and all claims, demands, actions,
          suits or proceedings, whether civil, criminal, administrative or investigative, in which any Indemnified Person may be involved,
          or is threatened to be involved, as a party or otherwise, under the Securities Act or otherwise (collectively, “Losses”),
          promptly as incurred, arising out of, based upon or resulting from any untrue statement or alleged untrue statement of any material
          fact contained in the Resale Shelf (or any amendment or supplement thereto), the related prospectus, or any amendment or supplement
          thereto, or arise out of, are based upon or resulting from the omission or alleged omission to state therein a material fact required
          to be stated therein or necessary to make the statements therein, in light of the circumstances in which they were made, not misleading;
          provided, however, that the Company shall not be liable in any such case or to any Indemnified Person to the extent, but only to
          the extent, that any such Loss arises out of, is based upon or results from an untrue statement or alleged untrue statement or
          omission or alleged omission or so made in reliance upon or in conformity with information furnished by or on behalf of such Indemnified
          Person in writing specifically for use in the preparation of the Resale Shelf, the related prospectus, or any amendment or supplement
          thereto. Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of such Indemnified
          Person, and shall survive the transfer of such securities by the Purchaser or any termination of this Agreement.

   

  		11.	The Company’s obligation under paragraph (1) of this Exhibit A is subject to the Purchaser furnishing to the Company
          in writing such information as the Company reasonably requests for use in connection with the Resale Shelf, the related prospectus,
          or any amendment or supplement thereto. The Purchaser shall severally, and not jointly with any other selling stockholder named
          in the Resale Shelf, indemnify the Company, its officers, directors, managers, employees, agents and representatives, and each
          person 

   

  
    
      

    

  

   

  	 	 	who controls the Company (within the meaning of the Securities Act) against any losses, claims, damages, liabilities and
          expenses resulting from any untrue statement or alleged untrue statement of material fact contained in the Resale Shelf, the related
          prospectus, or any amendment or supplement thereto or any omission or alleged omission of a material fact required to be stated
          therein or necessary to make the statements therein not misleading, but only to the extent that such untrue statement or omission
          is contained in any information so furnished in writing by the Purchaser expressly for inclusion in such document; provided that
          the obligation to indemnify shall be individual, not joint and several, for the Purchaser and shall be limited to the net amount
          of proceeds received by the Purchaser from the sale of Registrable Securities pursuant to the Resale Shelf.

   

  		12.	The Company shall cooperate with the Purchaser, to the extent the Registrable Securities become freely tradable, to facilitate
          the timely preparation and delivery of certificates (not bearing any restrictive legend) representing the Registrable Securities
          to be offered pursuant to a Resale Shelf and enable such certificates to be in such denominations or amounts, as the case may be,
          as the Purchaser may reasonably request and registered in such names as the Purchaser may request.

   

  		13.	If requested by the Purchaser, the Company shall as soon as practicable, subject to any Suspension Notice, (i) incorporate
          in a prospectus supplement or post-effective amendment such information as the Purchaser reasonably requests to be included therein
          relating to the sale and distribution of Registrable Securities, including, without limitation, information with respect to the
          number of Registrable Securities being offered or sold, the purchase price being paid therefor and any other terms of the offering
          of the Registrable Securities to be sold in such offering; (ii) make all required filings of such prospectus supplement or post-effective
          amendment after being notified of the matters to be incorporated in such prospectus supplement or post-effective amendment; and
          (iii) supplement or make amendments to any Registration Statement if reasonably requested by the Purchaser holding any Registrable
          Securities.

   

  		14.	As long as the Purchaser shall own Registrable Securities, the Company, at all times while it shall be reporting under the
          Exchange Act shall file timely (or obtain extensions in respect thereof and file within the applicable grace period) all reports
          required to be filed by the Company after the date hereof pursuant to Sections 13(a) or 15(d) of the Exchange Act and shall promptly
          furnish the Purchaser with true and complete copies of all such filings, unless filed through the SEC’s EDGAR system. The
          Company further covenants that it shall take such further action as the Purchaser may reasonably request, all to the extent required
          from time to time, to enable the Purchaser to sell the Class A Shares held by the Purchaser without registration under the Securities
          Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act, including providing any
          legal opinions. Upon the request of the Purchaser, the Company shall deliver to the Purchaser a written certification of a duly
          authorized officer as to whether it has complied with such requirements.

   

  		15.	The rights, duties and obligations of the Purchaser under this Exhibit A may be assigned or delegated by the Purchaser in conjunction
          with and to the extent of any transfer or assignment of Registrable Securities by the Purchaser to any transferee or assignee.

   

  
    
      

    

  

   

  		16.	Without limitation of the foregoing, in the event that the Company enters into a registration rights agreement with the Purchaser
          at or before the consummation of the Business Combination, the Purchaser will be entitled to the registration rights agreed to
          at the time of the Business Combination, which may replace the terms set forth on this Exhibit A.HTML Project Proof

  
    
      

      
        
          Exhibit 10.7

          

          

          

          INDEMNITY AGREEMENT

         

          

        THIS INDEMNITY AGREEMENT (this “Agreement”) is made as of January 6, 2021, by and between Altimeter Growth Corp. 2, a Cayman Islands exempted
          company (the “Company”), and _______________ (“Indemnitee”).

         

        

        WHEREAS, highly competent persons have become more reluctant to serve publicly-held companies and corporations as directors, officers or in other capacities unless they are provided with adequate
          protection through insurance or adequate indemnification against inordinate risks of claims and actions against them arising out of their service to and activities on behalf of such companies and corporations;

         

        

        WHEREAS, the Board of Directors of the Company (the “Board”) has determined that, in order to attract and retain qualified individuals, the
          Company will attempt to maintain on an ongoing basis, at its sole expense, liability insurance to protect persons serving the Company and its subsidiaries from certain liabilities. The amended and restated memorandum and articles of association
          of the Company (the “Articles”) provide for the indemnification of the officers and directors of the Company. Indemnitee may also be entitled to indemnification pursuant to applicable
          Cayman Islands law. The Articles provide that the indemnification provisions set forth therein are not exclusive, and thereby contemplate that contracts may be entered into between the Company and members of the Board, officers and other persons
          with respect to indemnification, hold harmless, exoneration, advancement and reimbursement rights;

         

        

        WHEREAS, the uncertainties relating to such insurance and to indemnification have increased the difficulty of attracting and retaining such persons;

         

        

        WHEREAS, the Board has determined that the increased difficulty in attracting and retaining such persons is detrimental to the best interests of the Company’s shareholders and that the Company should act
          to assure such persons that there will be increased certainty of such protection in the future;

         

        

        WHEREAS, it is reasonable, prudent and necessary for the Company contractually to obligate itself to indemnify, hold harmless, exonerate and to advance expenses on behalf of, such persons to the fullest
          extent permitted by applicable law and the Articles so that they will serve or continue to serve the Company free from undue concern that they will not be so protected against liabilities;

         

        

        WHEREAS, this Agreement is a supplement to and in furtherance of the Articles of the Company and any resolutions adopted pursuant thereto, and shall not be deemed a substitute therefor, nor to diminish
          or abrogate any rights of Indemnitee thereunder; and

         

        

        WHEREAS, Indemnitee may not be willing to serve as a director or officer of or in another capacity for the Company without adequate protection, and the Company desires Indemnitee to serve in such
          capacity. Indemnitee is willing to serve, continue to serve and to take on additional service for or on behalf of the Company on the condition that he or she be so indemnified.

         

        

        NOW, THEREFORE, in consideration of the premises and the covenants contained herein and subject to the provisions of the letter agreement dated as of January 6, 2021, the Company, Indemnitee and the
          other parties thereto do hereby covenant and agree as follows:

        

        

        	
                1.

              	
                SERVICES TO THE COMPANY

              

         

        

        In consideration of the Company’s covenants and obligations hereunder, Indemnitee will serve or continue to serve as a director or officer of or in another other capacity for the Company, as applicable, for so long as Indemnitee is duly
          elected or appointed or retained or until Indemnitee tenders his or her resignation or until Indemnitee is removed. The foregoing notwithstanding, this Agreement shall continue in full force and effect after Indemnitee has ceased to serve as a
          director or officer of or in another other capacity for the Company, as provided in Section 17. This Agreement, however, shall not impose any obligation on Indemnitee or the Company to continue Indemnitee’s service to the Company beyond any
          period otherwise required by applicable law and the Articles or by other agreements or commitments of the parties, if any.

        

        

        
          
            

        

        	
                2.

              	
                DEFINITIONS

              

         

        

        As used in this Agreement:

         

        

        (a)          References to “agent” shall mean any person who is or was a director or officer of or who serves or served in any other capacity for the Company or a subsidiary of the Company or other person authorized by the Company to act for
          the Company, to include such person serving in such capacity as a director or officer of or in another other capacity for another company, corporation, partnership, limited liability company, joint venture, trust or other enterprise at the
          request of, for the convenience of, or to represent the interests of the Company or a subsidiary of the Company.

         

        

        (b)          The terms “Beneficial Owner” and “Beneficial Ownership” shall have the meanings set forth in Rule 13d-3
          promulgated under the Exchange Act as in effect on the date hereof.

         

        

        (c)          “Delaware Court” shall mean the Court of Chancery of the State of Delaware.

         

        

        (d)          A “Change in Control” shall be deemed to occur upon the earliest to occur after the date of this Agreement of any of the following events:

         

        

        (i)          Acquisition of Shares by Third Party. Other than an affiliate of Altimeter Growth Holdings 2 (the “Sponsor”), any Person is or becomes the
          Beneficial Owner, directly or indirectly, of securities of the Company representing fifteen percent (15%) or more of the combined voting power of the Company’s then outstanding securities entitled to vote generally in the election of directors,
          unless (1) the change in the relative Beneficial Ownership of the Company’s securities by any Person results solely from a reduction in the aggregate number of outstanding shares of securities entitled to vote generally in the election of
          directors, or (2) such acquisition was approved in advance by the Continuing Directors and such acquisition would not constitute a Change in Control under part (iii) of this definition;

         

        

        (ii)         Change in Board of Directors. Individuals who, as of the date hereof, constitute the Board, and any new director whose election by the Board or nomination for election by the Company’s shareholders was
          approved by a vote of at least two thirds of the directors then still in office who were directors on the date hereof or whose election or nomination for election was previously so approved (collectively, the “Continuing Directors”), cease for any reason to constitute at least a majority of the members of the Board;

         

        

        (iii)        Corporate Transactions. The effective date of a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the Company and one or more businesses
          (a “Business Combination”), in each case, unless, following such Business Combination: (1) all or substantially all of the individuals and entities who were the Beneficial Owners of
          securities entitled to vote generally in the election of directors immediately prior to such Business Combination beneficially own, directly or indirectly, more than 51% of the combined voting power of the then outstanding securities of the
          Company entitled to vote generally in the election of directors resulting from such Business Combination (including, without limitation, a company or corporation which as a result of such transaction owns the Company or all or substantially all
          of the Company’s assets either directly or through one or more Subsidiaries) in substantially the same proportions as their ownership immediately prior to such Business Combination, of the securities entitled to vote generally in the election of
          directors; (2) other than an affiliate of the Sponsor, no Person (excluding any company or corporation resulting from such Business Combination) is the Beneficial Owner, directly or indirectly, of 15% or more of the combined voting power of the
          then outstanding securities entitled to vote generally in the election of directors of the surviving company or corporation except to the extent that such ownership existed prior to the Business Combination; and (3) at least a majority of the
          board of directors of the company or corporation resulting from such Business Combination were Continuing Directors at the time of the execution of the initial agreement, or of the action of the Board, providing for such Business Combination;

         

        

        (iv)        Liquidation. The approval by the shareholders of the Company of a complete liquidation of the Company or an agreement or series of agreements for the sale or disposition by the Company of all or
          substantially all of the Company’s assets, other than factoring the Company’s current receivables or escrows due (or, if such approval is not required, the decision by the Board to proceed with such a liquidation, sale, or disposition in one
          transaction or a series of related transactions); or

         

        

        (v)         Other Events. There occurs any other event of a nature that would be required to be reported in response to Item 6(e) of Schedule 14A of Regulation 14A (or a response to any similar item on any similar
          schedule or form) promulgated under the Exchange Act, whether or not the Company is then subject to such reporting requirement.

         

          

        

      
        
          

      

       
        (e)          “Corporate Status” describes the status of a person who is or was a director, officer, trustee, general partner, manager, managing member, fiduciary, employee or agent of
          the Company or of any other Enterprise which such person is or was serving at the request of the Company.

         

        

        (f)          “Disinterested Director” shall mean a director of the Company who is not and was not a party to the Proceeding in respect of which indemnification is sought by
          Indemnitee.

         

        

        (g)          “Enterprise” shall mean the Company and any other company or corporation, constituent company or corporation (including any constituent of a constituent) absorbed in a
          consolidation or merger to which the Company (or any of its wholly owned subsidiaries) is a party, limited liability company, partnership, joint venture, trust, employee benefit plan or other enterprise of which Indemnitee is or was serving at
          the request of the Company as a director or officer or in any other capacity.

         

        

        (h)          “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended.

         

        

        (i)          “Expenses” shall include all direct and indirect costs, fees and expenses of any type or nature whatsoever, including, without limitation, all reasonable attorneys’ fees
          and costs, retainers, court costs, transcript costs, fees of experts, witness fees, travel expenses, fees of private investigators and professional advisors, duplicating costs, printing and binding costs, telephone charges, postage, delivery
          service fees, fax transmission charges, secretarial services and all other disbursements, obligations or expenses in connection with prosecuting, defending, preparing to prosecute or defend, investigating, being or preparing to be a witness in,
          settlement or appeal of, or otherwise participating in, a Proceeding, including reasonable compensation for time spent by the Indemnitee for which he or she is not otherwise compensated by the Company or any third party. Expenses also shall
          include Expenses incurred in connection with any appeal resulting from any Proceeding, including without limitation the principal, premium, security for, and other costs relating to any cost bond, supersedeas bond, or other appeal bond or its
          equivalent. Expenses, however, shall not include amounts paid in settlement by Indemnitee or the amount of judgments or fines against Indemnitee.

         

        

        (j)           References to “fines” shall include any excise tax assessed on Indemnitee with respect to any employee benefit plan.

         

        

        (k)          References to “serving at the request of the Company” shall include any service as a director or officer of or in any other other capacity for the Company which imposes
          duties on, or involves services by, such director, officer or person with respect to an employee benefit plan, its participants or beneficiaries; and if Indemnitee acted in good faith and in a manner Indemnitee reasonably believed to be in the
          best interests of the participants and beneficiaries of an employee benefit plan, Indemnitee shall be deemed to have acted in a manner “not opposed to the best interests of the Company” as referred to in this Agreement.

         

        

        (l)          “Independent Counsel” shall mean a law firm or a member of a law firm with significant experience in matters of corporate law and that neither presently is, nor in the
          past five years has been, retained to represent: (i) the Company or Indemnitee in any matter material to either such party (other than with respect to matters concerning Indemnitee under this Agreement, or of other indemnitees under similar
          indemnification agreements); or (ii) any other party to the Proceeding giving rise to a claim for indemnification hereunder. Notwithstanding the foregoing, the term “Independent Counsel” shall not include any person who, under the applicable
          standards of professional conduct then prevailing, would have a conflict of interest in representing either the Company or Indemnitee in an action to determine Indemnitee’s rights under this Agreement.

         

        

        (m)         The term “Person” shall have the meaning as set forth in Sections 13(d) and 14(d) of the Exchange Act as in effect on the date hereof; provided, however, that “Person”
          shall exclude: (i) the Company; (ii) any Subsidiaries of the Company; (iii) any employment benefit plan of the Company or of a Subsidiary of the Company or of any company or corporation owned, directly or indirectly, by the shareholders of the
          Company in substantially the same proportions as their ownership of shares of the Company; and (iv) any trustee or other fiduciary holding securities under an employee benefit plan of the Company or of a Subsidiary of the Company or of a company
          or corporation owned directly or indirectly by the shareholders of the Company in substantially the same proportions as their ownership of shares of the Company.

         

        

        
          
            

        

        (n)          The term “Proceeding” shall include any threatened, pending or completed action, suit, arbitration, mediation, alternate dispute resolution mechanism, investigation,
          inquiry, administrative hearing or any other actual, threatened or completed proceeding, whether brought in the right of the Company or otherwise and whether of a civil (including intentional or unintentional tort claims), criminal,
          administrative or investigative or related nature, in which Indemnitee was, is, will or might be involved as a party or otherwise by reason of the fact that Indemnitee is or was a director or officer of, or serves or served in any other capacity
          for, the Company, by reason of any action (or failure to act) taken by him or her or of any action (or failure to act) on his or her part while acting as a director or officer of, or any other capacity for, the Company, or by reason of the fact
          that he or she is or was serving at the request of the Company as a director or officer of or in any other capacity for any other Enterprise, in each case whether or not serving in such capacity at the time any liability or expense is incurred
          for which indemnification, reimbursement, or advancement of expenses can be provided under this Agreement.

         

        

        (o)          The term “Subsidiary,” with respect to any Person, shall mean any company or corporation, limited liability company, partnership, joint venture, trust or other entity of
          which a majority of the voting power of the voting equity securities or equity interest is owned, directly or indirectly, by that Person.

         

        

        (p)          The phrase “to the fullest extent permitted by applicable law and the Articles” shall include, but not be limited to: (a) the fullest extent authorized or permitted by
          the provision or provisions of applicable Cayman Islands law that authorize or contemplate additional indemnification by agreement, or the corresponding provision of any amendment to or replacement of applicable Cayman Islands law, and (b) the
          fullest extent authorized or permitted by any amendments to or replacements of applicable Cayman Islands law adopted after the date of this Agreement that increase the extent to which a company or corporation may indemnify its officers or
          directors or those who serve in any other capacity.

        

        

        	
                3.

              	
                INDEMNITY IN THIRD-PARTY PROCEEDINGS

              

         

        

        To the fullest extent permitted by applicable law and the Articles, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Section 3 if Indemnitee was, is, or is threatened to be made, a
          party to or a participant (as a witness, deponent or otherwise) in any Proceeding, other than a Proceeding by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate Status. Pursuant to this Section
          3, Indemnitee shall be indemnified, held harmless and exonerated against all Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement (including all interest, assessments and other charges paid or payable in connection
          with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually, and reasonably incurred by Indemnitee or on his or her behalf in connection with such Proceeding or any claim, issue or matter therein, if
          Indemnitee acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company and, in the case of a criminal Proceeding, had no reasonable cause to believe that his or her conduct was
          unlawful; provided, in no event shall Indemnitee be entitled to be indemnified, held harmless or advanced any amounts hereunder in respect of any Expenses, judgments, liabilities, fines, penalties and amounts paid in settlement (if any) that
          Indemnitee may incur by reason of his or her own actual fraud or intentional misconduct. Indemnitee shall not be found to have committed actual fraud or intentional misconduct for any purpose of this Agreement unless or until a court of competent
          jurisdiction shall have made a finding to that effect.

        

        

        	
                4.

              	
                INDEMNITY IN PROCEEDINGS BY OR IN THE RIGHT OF THE COMPANY

              

         

        

        To the fullest extent permitted by applicable law and the Articles, the Company shall indemnify, hold harmless and exonerate Indemnitee in accordance with the provisions of this Section 4 if Indemnitee was, is, or is threatened to be made, a
          party to or a participant (as a witness, deponent or otherwise) in any Proceeding by or in the right of the Company to procure a judgment in its favor by reason of Indemnitee’s Corporate Status. Pursuant to this Section 4, Indemnitee shall be
          indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or her or on his or her behalf in connection with such Proceeding or any claim, issue or matter therein, if Indemnitee acted in good faith and
          in a manner he or she reasonably believed to be in or not opposed to the best interests of the Company. No indemnification, hold harmless or exoneration for Expenses shall be made under this Section 4 in respect of any claim, issue or matter as
          to which Indemnitee shall have been finally adjudged by a court of competent jurisdiction to be liable to the Company, unless and only to the extent that any court in which the Proceeding was brought or the Delaware Court shall determine upon
          application that, despite the adjudication of liability but in view of all the circumstances of the case, Indemnitee is fairly and reasonably entitled to indemnification, to be held harmless or to exoneration.

        

        

        
          
            

        

        	
                5.

              	
                INDEMNIFICATION FOR EXPENSES OF A PARTY WHO IS WHOLLY OR PARTLY SUCCESSFUL

              

         

        

        Notwithstanding any other provisions of this Agreement, but subject to Section 27, to the extent that Indemnitee was or is, by reason of Indemnitee’s Corporate Status, a party to (or a participant in) and is successful, on the merits or
          otherwise, in any Proceeding or in defense of any claim, issue or matter therein, in whole or in part, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate Indemnitee
          against all Expenses actually and reasonably incurred by him or her in connection therewith. If Indemnitee is not wholly successful in such Proceeding but is successful, on the merits or otherwise, as to one or more but less than all claims,
          issues or matters in such Proceeding, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate Indemnitee against all Expenses actually and reasonably incurred by him or her or
          on his or her behalf in connection with each successfully resolved claim, issue or matter. If Indemnitee is not wholly successful in such Proceeding, the Company also shall, to the fullest extent permitted by applicable law and the Articles,
          indemnify, hold harmless and exonerate Indemnitee against all Expenses reasonably incurred in connection with a claim, issue or matter related to any claim, issue, or matter on which Indemnitee was successful. For purposes of this Section 5 and
          without limitation, the termination of any claim, issue or matter in such a Proceeding by dismissal, with or without prejudice, shall be deemed to be a successful result as to such claim, issue or matter.

        

        

        	
                6.

              	
                INDEMNIFICATION FOR EXPENSES OF A WITNESS

              

         

        

        Notwithstanding any other provision of this Agreement, but subject to Section 27, to the extent that Indemnitee is, by reason of his or her Corporate Status, a witness or deponent in any Proceeding to which Indemnitee is not a party or
          threatened to be made a party, he or she shall, to the fullest extent permitted by applicable law and the Articles, be indemnified, held harmless and exonerated against all Expenses actually and reasonably incurred by him or her or on his or her
          behalf in connection therewith.

        

        

        	
                7.

              	
                ADDITIONAL INDEMNIFICATION, HOLD HARMLESS AND EXONERATION RIGHTS

              

         

        

        Notwithstanding any limitation in Sections 3, 4 or 5, but subject to Section 27, the Company shall, to the fullest extent permitted by applicable law and the Articles, indemnify, hold harmless and exonerate Indemnitee if Indemnitee is a party
          to or threatened to be made a party to any Proceeding (including a Proceeding by or in the right of the Company to procure a judgment in its favor) against all Expenses, judgments, fines, penalties and amounts paid in settlement (including all
          interest, assessments and other charges paid or payable in connection with or in respect of such Expenses, judgments, fines, penalties and amounts paid in settlement) actually and reasonably incurred by Indemnitee in connection with the
          Proceeding. No indemnification, hold harmless or exoneration rights shall be available under this Section 7 on account of Indemnitee’s conduct which constitutes a breach of Indemnitee’s duty of loyalty to the Company or its shareholders or is an
          act or omission not in good faith or which involves intentional misconduct or a knowing violation of the law.

        

        

        	
                8.

              	
                CONTRIBUTION IN THE EVENT OF JOINT LIABILITY

              

        

        

        (a)          To the fullest extent permissible under applicable law and the Articles, if the indemnification, hold harmless and/or exoneration rights provided for in this Agreement are unavailable to Indemnitee in whole or in part for any
          reason whatsoever, the Company, in lieu of indemnifying, holding harmless or exonerating Indemnitee, shall pay, in the first instance, the entire amount incurred by Indemnitee, whether for judgments, liabilities, fines, penalties, amounts paid or
          to be paid in settlement and/or for Expenses, in connection with any Proceeding without requiring Indemnitee to contribute to such payment, and the Company hereby waives and relinquishes any right of contribution it may have at any time against
          Indemnitee.

        

        

        (b)          The Company shall not enter into any settlement of any Proceeding in which the Company is jointly liable with Indemnitee (or would be if joined in such Proceeding) unless such settlement provides for a full and final release of
          all claims asserted against Indemnitee.

        

        

        (c)          The Company hereby agrees to fully indemnify, hold harmless and exonerate Indemnitee from any claims for contribution which may be brought by directors or officers of, or by those who serve in any other capacity for, the Company
          other than Indemnitee who may be jointly liable with Indemnitee. Indemnitee shall seek payments or advances from the Company only to the extent that such payments or advances are unavailable from any insurance policy of the Company covering
          Indemnitee.

         

        

        
          
            

        

        	
                9.

              	
                EXCLUSIONS

              

         

        

        Notwithstanding any provision in this Agreement, but subject to Section 27, the Company shall not be obligated under this Agreement to make any indemnification, advance Expenses, hold harmless or exoneration payment in connection with any
          claim made against Indemnitee:

         

        

        (a)          for which payment has actually been received by or on behalf of Indemnitee under any insurance policy or other indemnity or advancement provision and which payment has not subsequently been returned (provided that Indemnitee shall
          not be required to pursue any such potential insurance coverage, indemnity, or advancement), except with respect to any excess beyond the amount actually received under any insurance policy, contract, agreement, other indemnity or advancement
          provision or otherwise;

         

        

        (b)          for an accounting of profits made from the purchase and sale (or sale and purchase) by Indemnitee of securities of the Company within the meaning of Section 16(b) of the Exchange Act (or any successor rule) or similar provisions
          of state statutory law or common law; or

         

        

        (c)          except as otherwise provided in Sections 14(f) and (g) hereof, prior to a Change in Control, in connection with any Proceeding (or any part of any Proceeding) initiated by Indemnitee, including any Proceeding (or any part of any
          Proceeding) initiated by Indemnitee against the Company or its directors, officers or other indemnitees, unless (i) the Board authorized the Proceeding (or any part of any Proceeding) prior to its initiation or (ii) the Company provides the
          indemnification, hold harmless or exoneration payment, in its sole discretion, pursuant to the powers vested in the Company under applicable law and the Articles.

        

        

        	
                10.

              	
                ADVANCES OF EXPENSES; DEFENSE OF CLAIM

              

        

        

        (a)          Notwithstanding any provision of this Agreement to the contrary, but subject to Section 27, and to the fullest extent not prohibited by applicable law and the Articles, the Company shall pay the Expenses incurred by Indemnitee (or
          reasonably expected by Indemnitee to be incurred by Indemnitee within three months) in connection with any Proceeding within ten (10) days after the receipt by the Company of a statement or statements requesting such advances from time to time,
          prior to the final disposition of any Proceeding. Advances shall, to the fullest extent permitted by applicable law and the Articles, be unsecured and interest free. Advances shall, to the fullest extent permitted by applicable law and the
          Articles, be made without regard to Indemnitee’s ability to repay the Expenses and without regard to Indemnitee’s ultimate entitlement to be indemnified, held harmless or exonerated under the other provisions of this Agreement. Advances shall
          include any and all reasonable Expenses incurred pursuant to a Proceeding to enforce this right of advancement, including Expenses incurred preparing and forwarding statements to the Company to support the advances claimed. Solely to the extent
          required by applicable law and the Articles, such payments of Expenses in advance of the final disposition of the Proceeding shall be made only upon the Company’s receipt of an undertaking, by or on behalf of Indemnitee, to repay the advanced
          amounts to the extent that it is ultimately determined that Indemnitee is not entitled to be indemnified by the Company under the provisions of this Agreement, applicable law and the Articles or otherwise. If it shall be determined by a final
          judgment or other final adjudication that Indemnitee was not so entitled to indemnification, any advancement shall be returned to the Company (without interest) by the Indemnitee. This Section 10(a) shall not apply to any claim made by Indemnitee
          for which an indemnification, hold harmless or exoneration payment is excluded pursuant to Section 9, but shall apply to any Proceeding referenced in Section 9(b) prior to a final determination that Indemnitee is liable therefor.

        

        

        (b)          Indemnitee shall have the sole right and obligation to control the defense or conduct of any claim or Proceeding with respect to Indemnitee.  The Company will be entitled to participate in the Proceeding at its own expense.

        

        

        (c)          The Company shall not settle any action, claim or Proceeding (in whole or in part) which would impose any Expense, judgment, fine, penalty or limitation on Indemnitee without Indemnitee’s prior written consent.

        

        

        
          
            

        

        	
                11.

              	
                PROCEDURE FOR NOTIFICATION AND APPLICATION FOR INDEMNIFICATION

              

        

        

        (a)          Indemnitee agrees to notify promptly the Company in writing upon being served with any summons, citation, subpoena, complaint, indictment, information or other document relating to any Proceeding, claim, issue or matter therein
          which may be subject to indemnification, hold harmless or exoneration rights, or advancement of Expenses covered hereunder. The failure of Indemnitee to so notify the Company shall not relieve the Company of any obligation which it may have to
          Indemnitee under this Agreement, or otherwise.

        

        

        (b)          Indemnitee may deliver to the Company a written application to indemnify, hold harmless or exonerate Indemnitee in accordance with this Agreement. Such application(s) may be delivered from time to time and at such time(s) as
          Indemnitee deems appropriate in his or her sole discretion. Following such a written application for indemnification by Indemnitee, Indemnitee’s entitlement to indemnification shall be determined according to Section 12(a) of this Agreement.

         

        

        	
                12.

              	
                PROCEDURE UPON APPLICATION FOR INDEMNIFICATION

              

        

        

        (a)          A determination, if required by applicable law and the Articles, with respect to Indemnitee’s entitlement to indemnification shall be made in the specific case by one of the following methods, which shall be at the election of
          Indemnitee: (i) by a majority vote of the Disinterested Directors, even though less than a quorum of the Board, (ii) by a committee of such directors designated by majority vote of such directors, (iii) if there are no Disinterested Directors or
          if such directors so direct, by Independent Counsel in a written opinion to the Board, a copy of which shall be delivered to Indemnitee, or (iv) by vote of the shareholders by ordinary resolution. The Company promptly will advise Indemnitee in
          writing with respect to any determination that Indemnitee is or is not entitled to indemnification, including a description of any reason or basis for which indemnification has been denied. If it is so determined that Indemnitee is entitled to
          indemnification, payment to Indemnitee shall be made within ten (10) days after such determination. Indemnitee shall reasonably cooperate with the person, persons or entity making such determination with respect to Indemnitee’s entitlement to
          indemnification, including providing to such person, persons or entity upon reasonable advance request any documentation or information which is not privileged or otherwise protected from disclosure and which is reasonably available to Indemnitee
          and reasonably necessary to such determination. Any costs or Expenses (including reasonable attorneys’ fees and disbursements) incurred by Indemnitee in so cooperating with the person, persons or entity making such determination shall be borne by
          the Company (irrespective of the determination as to Indemnitee’s entitlement to indemnification) and the Company hereby agrees to indemnify and to hold Indemnitee harmless therefrom.

        

        

        (b)          In the event the determination of entitlement to indemnification is to be made by Independent Counsel pursuant to Section 12(a) hereof, the Independent Counsel shall be selected as provided in this Section 12(b). The Independent
          Counsel shall be selected by Indemnitee (unless Indemnitee shall request that such selection be made by the Board), and Indemnitee shall give written notice to the Company advising it of the identity of the Independent Counsel so selected and
          certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement. If the Independent Counsel is selected by the Board, the Company shall give written notice to
          Indemnitee advising him or her of the identity of the Independent Counsel so selected and certifying that the Independent Counsel so selected meets the requirements of “Independent Counsel” as defined in Section 2 of this Agreement. In either
          event, Indemnitee or the Company, as the case may be, may, within ten (10) days after such written notice of selection shall have been received, deliver to the Company or to Indemnitee, as the case may be, a written objection to such selection;
          provided, however, that such objection may be asserted only on the ground that the Independent Counsel so selected does not meet the requirements of “Independent Counsel” as defined in Section 2 of this Agreement, and the objection shall set
          forth with particularity the factual basis of such assertion. Absent a proper and timely objection, the person so selected shall act as Independent Counsel. If such written objection is so made and substantiated, the Independent Counsel so
          selected may not serve as Independent Counsel unless and until such objection is withdrawn or a court of competent jurisdiction has determined that such objection is without merit. If, within twenty (20) days after submission by Indemnitee of a
          written request for indemnification pursuant to Section 11(b) hereof, no Independent Counsel shall have been selected and not objected to, either the Company or Indemnitee may petition the Delaware Court for resolution of any objection which
          shall have been made by the Company or Indemnitee to the other’s selection of Independent Counsel and/or for the appointment as Independent Counsel of a person selected by the Delaware Court, and the person with respect to whom all objections are
          so resolved or the person so appointed shall act as Independent Counsel under Section 12(a) hereof. Upon the due commencement of any judicial proceeding or arbitration pursuant to Section 14(a) of this Agreement, Independent Counsel shall be
          discharged and relieved of any further responsibility in such capacity (subject to the applicable standards of professional conduct then prevailing).

        

        

        
          
            

        

        (c)          The Company agrees to pay the reasonable fees and expenses of Independent Counsel and to fully indemnify and hold harmless such Independent Counsel against any and all Expenses, claims, liabilities and damages arising out of or
        relating to this Agreement or its engagement pursuant hereto.
        

        

        	
                13.

              	
                PRESUMPTIONS AND EFFECT OF CERTAIN PROCEEDINGS

              

        

        

        (a)          In making a determination with respect to entitlement to indemnification hereunder, the person, persons or entity making such determination shall presume that Indemnitee is entitled to indemnification under this Agreement if
          Indemnitee has submitted a request for indemnification in accordance with Section 11(b) of this Agreement, and the Company shall have the burden of proof to overcome that presumption in connection with the making by any person, persons or entity
          of any determination contrary to that presumption. Neither the failure of the Company (including by the Disinterested Directors or Independent Counsel) to have made a determination prior to the commencement of any action pursuant to this
          Agreement that indemnification is proper in the circumstances because Indemnitee has met the applicable standard of conduct, nor an actual determination by the Company (including by the Disinterested Directors or Independent Counsel) that
          Indemnitee has not met such applicable standard of conduct, shall be a defense to the action or create a presumption that Indemnitee has not met the applicable standard of conduct.

        

        

        (b)          If the person, persons or entity empowered or selected under Section 12 of this Agreement to determine whether Indemnitee is entitled to indemnification shall not have made a determination within thirty (30) days after receipt by
          the Company of the request therefor, the requisite determination of entitlement to indemnification shall, to the fullest extent permitted by applicable law and the Articles, be deemed to have been made and Indemnitee shall be entitled to such
          indemnification, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for indemnification, or (ii) a final
          judicial determination that any or all such indemnification is expressly prohibited under applicable law and the Articles; provided, however, that such 30-day period may be extended for a reasonable time, not to exceed an additional fifteen (15)
          days, if the person, persons or entity making the determination with respect to entitlement to indemnification in good faith requires such additional time for the obtaining or evaluating of documentation and/or information relating thereto.

        

        

        (c)          The termination of any Proceeding or of any claim, issue or matter therein, by judgment, order, settlement or conviction, or upon a plea of nolo contendere or its equivalent, shall not (except as otherwise expressly provided in
          this Agreement) of itself adversely affect the right of Indemnitee to indemnification or create a presumption that Indemnitee did not act in good faith and in a manner which he or she reasonably believed to be in or not opposed to the best
          interests of the Company or, with respect to any criminal Proceeding, that Indemnitee had reasonable cause to believe that his or her conduct was unlawful.

        

        

        (d)          For purposes of any determination of good faith, Indemnitee shall be deemed to have acted in good faith if Indemnitee’s action is based on the records or books of account of the Enterprise, including financial statements, or on
          information supplied to Indemnitee by the directors or officers of, or by those who serve in any other capacity for, the Enterprise in the course of their duties, or on the advice of legal counsel for the Enterprise, its Board, any committee of
          the Board or any director or officer of, or any person who served in any capacity form the Enterprise, or on information or records given or reports made to the Enterprise, its Board, any committee of the Board or any director or officer of, any
          person who served in any capacity for, the Enterprise, by an independent certified public accountant or by an appraiser or other expert selected by the Enterprise, its Board, any committee of the Board or any director or officer of, or any person
          who serves in any capacity for, the Enterprise. The provisions of this Section 13(d) shall not be deemed to be exclusive or to limit in any way the other circumstances in which Indemnitee may be deemed or found to have met the applicable standard
          of conduct set forth in this Agreement.

        

        

        (e)          The knowledge and/or actions, or failure to act, of any other director or officer of any other person who serves in any capacity to act for the Enterprise shall not be imputed to Indemnitee for purposes of determining the right to
          indemnification under this Agreement.

        

        

        
          
            

        

        	
                14.

              	
                REMEDIES OF INDEMNITEE

              

         

        

        (a)          In the event that (i) a determination is made pursuant to Section 12 of this Agreement that Indemnitee is not entitled to indemnification under this Agreement, (ii) advancement of Expenses, to the fullest extent permitted by
          applicable law and the Articles, is not timely made pursuant to Section 10 of this Agreement, (iii) no determination of entitlement to indemnification shall have been made pursuant to Section 12(a) of this Agreement within thirty (30) days after
          receipt by the Company of the request for indemnification, (iv) payment of indemnification is not made pursuant to Sections 5, 6, 7 or the last sentence of Section 12(a) of this Agreement within ten (10) days after receipt by the Company of a
          written request therefor, (v) a contribution payment is not made in a timely manner pursuant to Section 8 of this Agreement, (vi) payment of indemnification pursuant to Section 3 or 4 of this Agreement is not made within ten (10) days after a
          determination has been made that Indemnitee is entitled to indemnification, or (vii) payment to Indemnitee pursuant to any hold harmless or exoneration rights under this Agreement or otherwise is not made in accordance with this Agreement within
          ten (10) days after receipt by the Company of a written request therefor, Indemnitee shall be entitled to an adjudication by the Delaware Court to such indemnification, hold harmless, exoneration, contribution or advancement rights.
          Alternatively, Indemnitee, at his or her option, may seek an award in arbitration to be conducted by a single arbitrator pursuant to the Commercial Arbitration Rules and Mediation Procedures of the American Arbitration Association. Except as set
          forth herein, the Commercial Arbitration Rules and Mediation Procedures of the American Arbitration Association shall apply to any such arbitration. The Company shall not oppose Indemnitee’s right to seek any such adjudication or award in
          arbitration.

         

        

        (b)          In the event that a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is not entitled to indemnification, any judicial proceeding or arbitration commenced pursuant to this Section 14
          shall be conducted in all respects as a de novo trial, or arbitration, on the merits and Indemnitee shall not be prejudiced by reason of that adverse determination.

         

        

        (c)          In any judicial proceeding or arbitration commenced pursuant to this Section 14, Indemnitee shall be presumed to be entitled to be indemnified, held harmless, exonerated to receive advancement of Expenses under this Agreement and
          the Company shall have the burden of proving Indemnitee is not entitled to be indemnified, held harmless, exonerated and to receive advancement of Expenses, as the case may be, and the Company may not refer to or introduce into evidence any
          determination pursuant to Section 12(a) of this Agreement adverse to Indemnitee for any purpose. If Indemnitee commences a judicial proceeding or arbitration pursuant to this Section 14, Indemnitee shall not be required to reimburse the Company
          for any advances pursuant to Section 10 until a final determination is made with respect to Indemnitee’s entitlement to indemnification (as to which all rights of appeal have been exhausted or lapsed).

         

        

        (d)          If a determination shall have been made pursuant to Section 12(a) of this Agreement that Indemnitee is entitled to indemnification, the Company shall be bound by such determination in any judicial proceeding or arbitration
          commenced pursuant to this Section 14, absent (i) a misstatement by Indemnitee of a material fact, or an omission of a material fact necessary to make Indemnitee’s statement not materially misleading, in connection with the request for
          indemnification, or (ii) a prohibition of such indemnification under applicable law and the Articles.

         

        

        (e)          The Company shall be precluded from asserting in any judicial proceeding or arbitration commenced pursuant to this Section 14 that the procedures and presumptions of this Agreement are not valid, binding and enforceable and shall
          stipulate in any such court or before any such arbitrator that the Company is bound by all the provisions of this Agreement.

         

        

        (f)           The Company shall indemnify and hold harmless Indemnitee to the fullest extent permitted by applicable law and the Articles against all Expenses and, if requested by Indemnitee, shall (within ten (10) days after the Company’s
          receipt of such written request) pay to Indemnitee, to the fullest extent permitted by applicable law, such Expenses which are incurred by Indemnitee in connection with any judicial proceeding or arbitration brought by Indemnitee: (i) to enforce
          his or her rights under, or to recover damages for breach of, this Agreement or any other indemnification, hold harmless, exoneration, advancement or contribution agreement or provision of the Articles now or hereafter in effect; or (ii) for
          recovery or advances under any insurance policy maintained by any person for the benefit of Indemnitee, regardless of the outcome and whether Indemnitee ultimately is determined to be entitled to such indemnification, hold harmless or exoneration
          right, advancement, contribution or insurance recovery, as the case may be (unless such judicial proceeding or arbitration was not brought by Indemnitee in good faith).

         

        

        
          
            

        

        (g)          Interest shall be paid by the Company to Indemnitee at the legal rate under Delaware law for amounts which the Company indemnifies, holds harmless or exonerates, or advances, or is obliged to indemnify, hold harmless or exonerate
          or advance for the period commencing with the date on which Indemnitee requests indemnification, to be held harmless, exonerated, contribution, reimbursement or advancement of any Expenses and ending with the date on which such payment is made to
          Indemnitee by the Company.

        

        

        	
                15.

              	
                SECURITY

              

         

        

        Notwithstanding anything herein to the contrary, but subject to Section 27, to the extent requested by Indemnitee and approved by the Board, the Company may at any time and from time to time provide security to Indemnitee for the Company’s
          obligations hereunder through an irrevocable bank line of credit, funded trust or other collateral. Any such security, once provided to Indemnitee, may not be revoked or released without the prior written consent of Indemnitee.

        

        

        	
                16.

              	
                NON-EXCLUSIVITY; SURVIVAL OF RIGHTS; INSURANCE; SUBROGATION; PRIORITY OF OBLIGATIONS

              

         

        

        (a)          The rights of Indemnitee as provided by this Agreement shall not be deemed exclusive of any other rights to which Indemnitee may at any time be entitled under applicable law and the Articles, any agreement, a vote of shareholders
          or a resolution of directors, or otherwise. No amendment, alteration or repeal of this Agreement or of any provision hereof shall limit or restrict any right of Indemnitee under this Agreement in respect of any Proceeding (regardless of when such
          Proceeding is first threatened, commenced or completed) or claim, issue or matter therein arising out of, or related to, any action taken or omitted by such Indemnitee in his or her Corporate Status prior to such amendment, alteration or repeal.
          To the extent that a change in applicable law and the Articles, whether by statute or judicial decision, permits greater indemnification, hold harmless or exoneration rights or advancement of Expenses than would be afforded currently under the
          Articles or this Agreement, then this Agreement (without any further action by the parties hereto) shall automatically be deemed to be amended to require that the Company indemnify the Indemnitee to the fullest extent permitted by applicable law
          and the Articles. No right or remedy herein conferred is intended to be exclusive of any other right or remedy, and every other right and remedy shall be cumulative and in addition to every other right and remedy given hereunder or now or
          hereafter existing at law or in equity or otherwise. The assertion or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other right or remedy.

        

        

        (b)          The Articles permit the Company to purchase and maintain insurance or furnish similar protection or make other arrangements including, but not limited to, providing a trust fund, letter of credit, or surety bond (“Indemnification Arrangements”) on behalf of Indemnitee against any liability asserted against him or her or incurred by or on behalf of him or her or in such capacity as a director, officer
          or agent of the Company, or arising out of his or her status as such, whether or not the Company would have the power to indemnify him or her against such liability under the provisions of this Agreement and the Articles. The purchase,
          establishment, and maintenance of any such Indemnification Arrangement shall not in any way limit or affect the rights and obligations of the Company or of Indemnitee under this Agreement except as expressly provided herein, and the execution and
          delivery of this Agreement by the Company and Indemnitee shall not in any way limit or affect the rights and obligations of the Company or the other party or parties thereto under any such Indemnification Arrangement.

        

        

        (c)          To the extent that the Company maintains an insurance policy or policies providing liability insurance for directors or officers of, or those who serve in any other capacity for, any other Enterprise which such person serves at
          the request of the Company, Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director or officer or person serving in any other capacity
          under such policy or policies. If, at the time the Company receives notice from any source of a Proceeding as to which Indemnitee is a party or a participant (as a witness, deponent or otherwise), the Company has director and officer liability
          insurance in effect, the Company shall give prompt notice of such Proceeding to the insurers in accordance with the procedures set forth in the respective policies. The Company shall thereafter use commercially reasonable efforts to cause such
          insurers to pay, on behalf of Indemnitee, all amounts payable as a result of such Proceeding in accordance with the terms of such policies.

         

        

        
          
            

        

        (d)          In the event of any payment under this Agreement, the Company, to the fullest extent permitted by applicable law and the Articles, shall be subrogated to the extent of such payment to all of the rights of recovery of Indemnitee,
          who shall execute all papers required and take all action necessary to secure such rights, including execution of such documents as are necessary to enable the Company to bring suit to enforce such rights. No such payment by the Company shall be
          deemed to relieve any insurer of its obligations.

        

        

        (e)          The Company’s obligation to indemnify, hold harmless, exonerate or advance Expenses hereunder to Indemnitee who is or was serving at the request of the Company as a director or officer of or in any other capacity for any other
          Enterprise shall be reduced by any amount Indemnitee has actually received as indemnification, hold harmless or exoneration payments or advancement of expenses from such Enterprise. Notwithstanding any other provision of this Agreement to the
          contrary, but subject to Section 27, (i) Indemnitee shall have no obligation to reduce, offset, allocate, pursue or apportion any indemnification, hold harmless, exoneration, advancement, contribution or insurance coverage among multiple parties
          possessing such duties to Indemnitee prior to the Company’s satisfaction and performance of all its obligations under this Agreement, and (ii) the Company shall perform fully its obligations under this Agreement without regard to whether
          Indemnitee holds, may pursue or has pursued any indemnification, advancement, hold harmless, exoneration, contribution or insurance coverage rights against any person or entity other than the Company.

        

        

        (f)           Notwithstanding anything contained herein, the Company is the primary indemnitor, and any indemnification or advancement obligation of the Sponsor or its affiliates or members or any other Person, and any insurance maintained by
          the Sponsor or its affiliates or members, is secondary.

        

        

        	
                17.

              	
                DURATION OF AGREEMENT

              

         

        

        All agreements and obligations of the Company contained herein shall continue during the period Indemnitee serves as a director or officer of the Company or as a director or officer of or in any other capacity for any other company or
          corporation, partnership, joint venture, trust, employee benefit plan or other Enterprise which Indemnitee serves at the request of the Company and shall continue thereafter so long as Indemnitee shall be subject to any possible Proceeding
          (including any rights of appeal thereto and any Proceeding commenced by Indemnitee pursuant to Section 14 of this Agreement) by reason of his or her Corporate Status, whether or not he or she is acting in any such capacity at the time any
          liability or expense is incurred for which indemnification or advancement can be provided under this Agreement.

        

        

        	
                18.

              	
                SEVERABILITY

              

         

        

        If any provision or provisions of this Agreement shall be held to be invalid, illegal or unenforceable for any reason whatsoever: (a) the validity, legality and enforceability of the remaining provisions of this Agreement (including, without
          limitation, each portion of any Section, paragraph or sentence of this Agreement containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall not in any way be affected or
          impaired thereby and shall remain enforceable to the fullest extent permitted by applicable law and the Articles; (b) such provision or provisions shall be deemed reformed to the extent necessary to conform to applicable law and the Articles and
          to give the maximum effect to the intent of the parties hereto; and (c) to the fullest extent possible, the provisions of this Agreement (including, without limitation, each portion of any Section, paragraph or sentence of this Agreement
          containing any such provision held to be invalid, illegal or unenforceable, that is not itself invalid, illegal or unenforceable) shall be construed so as to give effect to the intent manifested thereby.

        

        

        	
                19.

              	
                ENFORCEMENT AND BINDING EFFECT

              

         

        

        (a)          The Company expressly confirms and agrees that it has entered into this Agreement and assumed the obligations imposed on it hereby in order to induce Indemnitee to serve as a director or officer of or in another capacity for the
          Company, and the Company acknowledges that Indemnitee is relying upon this Agreement in serving as a director or officer of or in another capacity for the Company.

         

        

        
          
            

        

        (b)          Without limiting any of the rights of Indemnitee under the Articles of the Company as they may be amended from time to time, this Agreement constitutes the entire agreement between the parties hereto with respect to the subject
          matter hereof and supersedes all prior agreements and understandings, oral, written and implied, between the parties hereto with respect to the subject matter hereof.

         

        

        (c)          The indemnification, hold harmless, exoneration and advancement of expenses rights provided by or granted pursuant to this Agreement shall be binding upon and be enforceable by the parties hereto and their respective successors
          and assigns (including any direct or indirect successor by purchase, merger, consolidation or otherwise to all or substantially all of the business and/or assets of the Company), shall continue as to an Indemnitee who has ceased to be a director
          or officer of or to serve in any other capacity for the Company or ceased to be a director or officer of or to serve in any other capacity for any other Enterprise at the Company’s request, and shall inure to the benefit of Indemnitee and his or
          her spouse, assigns, heirs, devisees, executors and administrators and other legal representatives.

         

        

        (d)          The Company shall require and cause any successor (whether direct or indirect by purchase, merger, consolidation or otherwise) to all, substantially all or a substantial part, of the business and/or assets of the Company, by
          written agreement in form and substance satisfactory to Indemnitee, expressly to assume and agree to perform this Agreement in the same manner and to the same extent that the Company would be required to perform if no such succession had taken
          place.

         

        

        (e)          The Company and Indemnitee agree herein that a monetary remedy for breach of this Agreement, at some later date, may be inadequate, impracticable and difficult of proof, and further agree that such breach may cause Indemnitee
          irreparable harm. Accordingly, the parties hereto agree that Indemnitee may, to the fullest extent permitted by applicable law and the Articles, enforce this Agreement by seeking, among other things, injunctive relief and/or specific performance
          hereof, without any necessity of showing actual damage or irreparable harm and that by seeking injunctive relief and/or specific performance, Indemnitee shall not be precluded from seeking or obtaining any other relief to which he or she may be
          entitled. The Company and Indemnitee further agree that Indemnitee shall, to the fullest extent permitted by applicable law and the Articles, be entitled to such specific performance and injunctive relief, including temporary restraining orders,
          preliminary injunctions and permanent injunctions, without the necessity of posting bonds or other undertaking in connection therewith. The Company acknowledges that in the absence of a waiver, a bond or undertaking may be required of Indemnitee
          by a court of competent jurisdiction, and the Company hereby waives any such requirement of such a bond or undertaking to the fullest extent permitted by applicable law and the Articles.

         

        

        	
                20.

              	
                MODIFICATION AND WAIVER

              

         

        

        No supplement, modification or amendment of this Agreement shall be binding unless executed in writing by the parties hereto. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other
          provisions of this Agreement nor shall any waiver constitute a continuing waiver.

        

        

        	
                21.

              	
                NOTICES

              

         

        

        All notices, requests, demands and other communications under this Agreement shall be in writing and shall be deemed to have been duly given (i) if delivered by hand and receipted for by the party to whom said notice or other communication
          shall have been directed, or (ii) if mailed by certified or registered mail with postage prepaid, on the third (3rd) business day after the date on which it is so mailed:

         

        

        (a)          If to Indemnitee, at the address indicated on the signature page of this Agreement, or such other address as Indemnitee shall provide in writing to the Company.

         

        

        (b)          If to the Company, to:

        

        

        Altimeter Growth Corp. 2

        2550 Sand Hill Road

        Suite 150

        Menlo Park, CA 94025

        Attention: Hab Siam

         

        

        
          
            

        

        With a copy, which shall not constitute notice, to:

        

        

        Ropes & Gray LLP

        1211 Avenue of the Americas

        New York, New York 10036

        Attention: Paul D. Tropp

        Michael S. Pilo

         

        

        or to any other address as may have been furnished to Indemnitee in writing by the Company.

        

        

        	
                22.

              	
                APPLICABLE LAW AND CONSENT TO JURISDICTION

              

         

        

        This Agreement and the legal relations among the parties shall be governed by, and construed and enforced in accordance with, the laws of the State of Delaware, without regard to its conflict of laws rules. Except with respect to any
          arbitration commenced by Indemnitee pursuant to Section 14(a) of this Agreement, to the fullest extent permitted by applicable law and the Articles, the Company and Indemnitee hereby irrevocably and unconditionally: (a) agree that any action or
          proceeding arising out of or in connection with this Agreement shall be brought only in the Delaware Court and not in any other state or federal court in the United States of America or any court in any other country; (b) consent to submit to the
          exclusive jurisdiction of the Delaware Court for purposes of any action or proceeding arising out of or in connection with this Agreement; (c) waive any objection to the laying of venue of any such action or proceeding in the Delaware Court; and
          (d) waive, and agree not to plead or to make, any claim that any such action or proceeding brought in the Delaware Court has been brought in an improper or inconvenient forum, or is subject (in whole or in part) to a jury trial. To the fullest
          extent permitted by applicable law and the Articles, the parties hereby agree that the mailing of process and other papers in connection with any such action or proceeding in the manner provided by Section 21 or in such other manner as may be
          permitted by applicable law and the Articles, shall be valid and sufficient service thereof.

        

        

        	
                23.

              	
                IDENTICAL COUNTERPARTS

              

         

        

        This Agreement may be executed in one or more counterparts, each of which shall for all purposes be deemed to be an original but all of which together shall constitute one and the same Agreement. Only one such counterpart signed by the party
          against whom enforceability is sought needs to be produced to evidence the existence of this Agreement.

        

        

        	
                24.

              	
                MISCELLANEOUS

              

         

        

        The headings of the paragraphs of this Agreement are inserted for convenience only and shall not be deemed to constitute part of this Agreement or to affect the construction thereof.

        

        

        	
                25.

              	
                PERIOD OF LIMITATIONS

              

         

        

        No legal action shall be brought and no cause of action shall be asserted by or in the right of the Company against Indemnitee, Indemnitee’s spouse, heirs, executors or personal or legal representatives after the expiration of two years from
          the date of accrual of such cause of action, and any claim or cause of action of the Company shall be extinguished and deemed released unless asserted by the timely filing of a legal action within such two-year period; provided, however, that if
          any shorter period of limitations is otherwise applicable to any such cause of action such shorter period shall govern.

        

        

        	
                26.

              	
                ADDITIONAL ACTS

              

         

        

        If for the validation of any of the provisions in this Agreement any act, resolution, approval or other procedure is required to the fullest extent permitted by applicable law and the Articles, the Company undertakes to cause such act,
          resolution, approval or other procedure to be affected or adopted in a manner that will enable the Company to fulfill its obligations under this Agreement.

        

        

        
          
            

        

        	
                27.

              	
                WAIVER OF CLAIMS TO TRUST ACCOUNT

              

         

        

        Notwithstanding anything contained herein to the contrary, Indemnitee hereby agrees that it does not have any right, title, interest or claim of any kind (each, a “Claim”) in or to
          any monies in the trust account established in connection with the Company’s initial public offering for the benefit of the Company and holders of shares issued in such offering, and hereby waives any Claim it may have in the future as a result
          of, or arising out of, any services provided to the Company and will not seek recourse against such trust account for any reason whatsoever. Accordingly, Indemnitee acknowledges and agrees that any indemnification provided hereto will only be
          able to be satisfied by the Company if (i) the Company has sufficient funds outside of the trust account to satisfy its obligations hereunder or (ii) the Company consummates a Business Combination.

         

        

        	
                28.

              	
                MAINTENANCE OF INSURANCE

              

         

        

        The Company shall use commercially reasonable efforts to obtain and maintain in effect during the entire period for which the Company is obligated to indemnify the Indemnitee under this Agreement, one or more policies of insurance with
          reputable insurance companies to provide the officers/directors of the Company with coverage for losses from wrongful acts and omissions and to ensure the Company’s performance of its indemnification obligations under this Agreement. The
          Indemnitee shall be covered by such policy or policies in accordance with its or their terms to the maximum extent of the coverage available for any such director or officer or person serving in any other capacity under such policy or policies.
          In all such insurance policies, the Indemnitee shall be named as an insured in such a manner as to provide the Indemnitee with the same rights and benefits as are accorded to the most favorably insured of the directors and officers of or persons
          serving in any other capacity for the Company.

        

        

        [SIGNATURE PAGE FOLLOWS]

        

        

        
          
            

        

        IN WITNESS WHEREOF, the parties hereto have caused this Indemnity Agreement to be signed as of the day and year first above written.

         

        

        	 	
                ALTIMETER GROWTH CORP. 2

              
	 	 	 
	 	
                By:

              	

              
	 	 	
                Name: Hab Siam

              
	 	 	
                Title: General Counsel

              

        

        

        [Signature Page to Indemnity Agreement]

        

        

        
          
            

        

        	 	
                INDEMNITEE

              
	 	 
	 	

              
	 	
                Name:

              
	 	
                Title:

              

        

        

        [Signature Page to Indemnity Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]